{"status": "ok", "message-type": "work-list", "message-version": "1.0.0", "message": {"facets": {}, "total-results": 20393, "items": [{"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T22:45:49Z", "timestamp": 1574549149777}, "reference-count": 0, "publisher": "Bentham Science Publishers Ltd.", "issue": "1", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["CIEMD"], "published-print": {"date-parts": [[2014, 7, 30]]}, "DOI": "10.2174/22127070114019990002", "type": "journal-article", "created": {"date-parts": [[2014, 9, 27]], "date-time": "2014-09-27T09:46:28Z", "timestamp": 1411811188000}, "page": "11-19", "source": "Crossref", "is-referenced-by-count": 4, "title": ["Androgen Receptor Antagonists in the Treatment of Prostate Cancer"], "prefix": "10.2174", "volume": "1", "author": [{"given": "Takashi", "family": "Kawahara", "sequence": "first", "affiliation": []}, {"given": "Hiroshi", "family": "Miyamoto", "sequence": "additional", "affiliation": []}], "member": "965", "container-title": ["Clinical Immunology, Endocrine & Metabolic Drugs"], "language": "en", "link": [{"URL": "http://eurekaselect.com/article/download/113751", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2015, 11, 23]], "date-time": "2015-11-23T14:45:30Z", "timestamp": 1448289930000}, "score": 56.804028, "issued": {"date-parts": [[2014, 7, 30]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2014, 7, 30]]}, "issue": "1"}, "alternative-id": ["LiveAll1"], "URL": "http://dx.doi.org/10.2174/22127070114019990002", "ISSN": ["2212-7070"], "issn-type": [{"value": "2212-7070", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T00:41:17Z", "timestamp": 1574815277496}, "reference-count": 16, "publisher": "Elsevier BV", "issue": "6", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2017, 12, 1]], "date-time": "2017-12-01T00:00:00Z", "timestamp": 1512086400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": ["clinicalkey.jp", "clinicalkey.com", "clinical-genitourinary-cancer.com", "clinicalkey.es", "clinicalkey.fr", "clinicalkey.com.au", "elsevier.com", "sciencedirect.com"], "crossmark-restriction": true}, "short-container-title": ["Clinical Genitourinary Cancer"], "published-print": {"date-parts": [[2017, 12]]}, "DOI": "10.1016/j.clgc.2017.07.016", "type": "journal-article", "created": {"date-parts": [[2017, 7, 26]], "date-time": "2017-07-26T12:51:58Z", "timestamp": 1501073518000}, "page": "e1073-e1080", "update-policy": "http://dx.doi.org/10.1016/elsevier_cm_policy", "source": "Crossref", "is-referenced-by-count": 6, "title": ["Comparison of Sequential Treatment With Androgen Receptor-Targeted Agent Followed by\u00a0Another Androgen Receptor-Targeted Agent Versus Androgen Receptor-Targeted Agent Followed by Docetaxel in Chemotherapy-Naive Patients With Metastatic Castration-Resistant Prostate Cancer"], "prefix": "10.1016", "volume": "15", "author": [{"ORCID": "http://orcid.org/0000-0002-9203-4245", "authenticated-orcid": false, "given": "Nobuaki", "family": "Matsubara", "sequence": "first", "affiliation": []}, {"given": "Yoko", "family": "Yamada", "sequence": "additional", "affiliation": []}, {"given": "Ken-ichi", "family": "Tabata", "sequence": "additional", "affiliation": []}, {"given": "Takefumi", "family": "Satoh", "sequence": "additional", "affiliation": []}, {"given": "Naoto", "family": "Kamiya", "sequence": "additional", "affiliation": []}, {"given": "Hiroyoshi", "family": "Suzuki", "sequence": "additional", "affiliation": []}, {"given": "Takashi", "family": "Kawahara", "sequence": "additional", "affiliation": []}, {"given": "Hiroji", "family": "Uemura", "sequence": "additional", "affiliation": []}, {"ORCID": "http://orcid.org/0000-0001-8453-2474", "authenticated-orcid": false, "given": "Akihiro", "family": "Yano", "sequence": "additional", "affiliation": []}, {"given": "Satoru", "family": "Kawakami", "sequence": "additional", "affiliation": []}, {"given": "Masafumi", "family": "Otsuka", "sequence": "additional", "affiliation": []}, {"given": "Satoshi", "family": "Fukasawa", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Clinical Genitourinary Cancer"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S1558767317302136?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S1558767317302136?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 8, 29]], "date-time": "2018-08-29T23:56:10Z", "timestamp": 1535586970000}, "score": 34.476646, "issued": {"date-parts": [[2017, 12]]}, "references-count": 16, "journal-issue": {"published-print": {"date-parts": [[2017, 12]]}, "issue": "6"}, "alternative-id": ["S1558767317302136"], "URL": "http://dx.doi.org/10.1016/j.clgc.2017.07.016", "ISSN": ["1558-7673"], "issn-type": [{"value": "1558-7673", "type": "print"}], "assertion": [{"value": "Elsevier", "name": "publisher", "label": "This article is maintained by"}, {"value": "Comparison of Sequential Treatment With Androgen Receptor-Targeted Agent Followed by\u00a0Another Androgen Receptor-Targeted Agent Versus Androgen Receptor-Targeted Agent Followed by Docetaxel in Chemotherapy-Naive Patients With Metastatic Castration-Resistant Prostate Cancer", "name": "articletitle", "label": "Article Title"}, {"value": "Clinical Genitourinary Cancer", "name": "journaltitle", "label": "Journal Title"}, {"value": "https://doi.org/10.1016/j.clgc.2017.07.016", "name": "articlelink", "label": "CrossRef DOI link to publisher maintained version"}, {"value": "article", "name": "content_type", "label": "Content Type"}, {"value": "\u00a9 2017 Elsevier Inc. All rights reserved.", "name": "copyright", "label": "Copyright"}]}, {"indexed": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T22:58:08Z", "timestamp": 1574809088685}, "reference-count": 0, "publisher": "Impact Journals, LLC", "issue": "31", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Oncotarget"], "published-print": {"date-parts": [[2016, 8, 2]]}, "DOI": "10.18632/oncotarget.9994", "type": "journal-article", "created": {"date-parts": [[2016, 6, 14]], "date-time": "2016-06-14T11:53:27Z", "timestamp": 1465905207000}, "source": "Crossref", "is-referenced-by-count": 10, "title": ["Androgen receptor activity modulates responses to cisplatin treatment in bladder cancer"], "prefix": "10.18632", "volume": "7", "author": [{"given": "Eiji", "family": "Kashiwagi", "sequence": "first", "affiliation": []}, {"given": "Hiroki", "family": "Ide", "sequence": "additional", "affiliation": []}, {"given": "Satoshi", "family": "Inoue", "sequence": "additional", "affiliation": []}, {"given": "Takashi", "family": "Kawahara", "sequence": "additional", "affiliation": []}, {"given": "Yichun", "family": "Zheng", "sequence": "additional", "affiliation": []}, {"given": "Leonardo O.", "family": "Reis", "sequence": "additional", "affiliation": []}, {"given": "Alexander S.", "family": "Baras", "sequence": "additional", "affiliation": []}, {"given": "Hiroshi", "family": "Miyamoto", "sequence": "additional", "affiliation": []}], "member": "7892", "published-online": {"date-parts": [[2016, 6, 14]]}, "container-title": ["Oncotarget"], "language": "en", "link": [{"URL": "http://www.oncotarget.com/fulltext/9994", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 1, 15]], "date-time": "2018-01-15T12:10:04Z", "timestamp": 1516018204000}, "score": 28.672432, "issued": {"date-parts": [[2016, 6, 14]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2016, 8, 2]]}, "issue": "31"}, "alternative-id": ["9994"], "URL": "http://dx.doi.org/10.18632/oncotarget.9994", "ISSN": ["1949-2553"], "issn-type": [{"value": "1949-2553", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T10:23:09Z", "timestamp": 1574504589882}, "reference-count": 0, "publisher": "F1000 Research Ltd", "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2008, 1, 15]]}, "DOI": "10.3410/f.1098823.554967", "type": "dataset", "created": {"date-parts": [[2012, 9, 18]], "date-time": "2012-09-18T10:02:00Z", "timestamp": 1347962520000}, "source": "Crossref", "is-referenced-by-count": 0, "title": ["Faculty of 1000 evaluation for An androgen-regulated miRNA suppresses Bak1 expression and induces androgen-independent growth of prostate cancer cells."], "prefix": "10.3410", "author": [{"given": "Takashi", "family": "Tsuruo", "sequence": "first", "affiliation": []}], "member": "2560", "content-created": {"date-parts": [[2008, 1, 5]]}, "container-title": ["F1000 - Post-publication peer review of the biomedical literature"], "deposited": {"date-parts": [[2012, 9, 18]], "date-time": "2012-09-18T10:02:13Z", "timestamp": 1347962533000}, "score": 28.134773, "issued": {"date-parts": [[2008, 1, 5]]}, "references-count": 0, "URL": "http://dx.doi.org/10.3410/f.1098823.554967"}, {"indexed": {"date-parts": [[2019, 11, 25]], "date-time": "2019-11-25T18:23:25Z", "timestamp": 1574706205321}, "reference-count": 39, "publisher": "Wiley", "issue": "2", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1", "start": {"date-parts": [[2016, 10, 3]], "date-time": "2016-10-03T00:00:00Z", "timestamp": 1475452800000}, "delay-in-days": 0, "content-version": "tdm"}, {"URL": "http://onlinelibrary.wiley.com/termsAndConditions", "start": {"date-parts": [[2016, 10, 3]], "date-time": "2016-10-03T00:00:00Z", "timestamp": 1475452800000}, "delay-in-days": 0, "content-version": "vor"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Prostate"], "published-print": {"date-parts": [[2017, 2]]}, "DOI": "10.1002/pros.23263", "type": "journal-article", "created": {"date-parts": [[2016, 10, 7]], "date-time": "2016-10-07T16:18:42Z", "timestamp": 1475857122000}, "page": "222-233", "source": "Crossref", "is-referenced-by-count": 5, "title": ["Prostate Cancer Cells in Different Androgen Receptor Status Employ Different Leucine Transporters"], "prefix": "10.1002", "volume": "77", "author": [{"given": "Hideo", "family": "Otsuki", "sequence": "first", "affiliation": [{"name": "Department of Pharmacology and Toxicology; Kyorin University School of Medicine; Mitaka City Tokyo Japan"}]}, {"given": "Toru", "family": "Kimura", "sequence": "additional", "affiliation": [{"name": "Department of Pharmacology and Toxicology; Kyorin University School of Medicine; Mitaka City Tokyo Japan"}]}, {"given": "Takashi", "family": "Yamaga", "sequence": "additional", "affiliation": [{"name": "Department of Pharmacology and Toxicology; Kyorin University School of Medicine; Mitaka City Tokyo Japan"}]}, {"given": "Takeo", "family": "Kosaka", "sequence": "additional", "affiliation": [{"name": "Department of Urology; Keio University School of Medicine; Shinjuku-ku Tokyo Japan"}]}, {"given": "Jun-ichi", "family": "Suehiro", "sequence": "additional", "affiliation": [{"name": "Department of Pharmacology and Toxicology; Kyorin University School of Medicine; Mitaka City Tokyo Japan"}]}, {"given": "Hiroyuki", "family": "Sakurai", "sequence": "additional", "affiliation": [{"name": "Department of Pharmacology and Toxicology; Kyorin University School of Medicine; Mitaka City Tokyo Japan"}]}], "member": "311", "published-online": {"date-parts": [[2016, 10, 3]]}, "reference": [{"key": "10.1002/pros.23263-BIB0001|pros23263-cit-0001", "doi-asserted-by": "crossref", "first-page": "471", "DOI": "10.1016/j.cell.2006.01.016", "article-title": "Tor signaling in growth and metabolism", "volume": "124", "author": "Wullschleger", "year": "2006", "journal-title": "Cell"}, {"key": "10.1002/pros.23263-BIB0002|pros23263-cit-0002", "doi-asserted-by": "crossref", "first-page": "23629", "DOI": "10.1074/jbc.273.37.23629", "article-title": "Expression cloning and characterization of a transporter for large neutral amino acids activated by the heavy chain of 4F2 antigen (CD98)", "volume": "273", "author": "Kanai", "year": "1998", "journal-title": "J Biol Chem"}, {"key": "10.1002/pros.23263-BIB0003|pros23263-cit-0003", "doi-asserted-by": "crossref", "first-page": "142", "DOI": "10.1007/s00428-005-0063-7", "article-title": "LAT1 expression in normal lung and in atypical adenomatous hyperplasia and adenocarcinoma of the lung", "volume": "448", "author": "Nakanishi", "year": "2006", "journal-title": "Virchows Arch"}, {"key": "10.1002/pros.23263-BIB0004|pros23263-cit-0004", "doi-asserted-by": "crossref", "first-page": "484", "DOI": "10.1002/ijc.21866", "article-title": "L-type amino acid transporter 1 as a potential molecular target in human astrocytic tumors", "volume": "119", "author": "Nawashiro", "year": "2006", "journal-title": "Int J Cancer"}, {"key": "10.1002/pros.23263-BIB0005|pros23263-cit-0005", "doi-asserted-by": "crossref", "first-page": "7525", "DOI": "10.1158/0008-5472.CAN-11-1821", "article-title": "Androgen receptor and nutrient signaling pathways coordinate the demand for increased amino acid transport during prostate cancer progression", "volume": "71", "author": "Wang", "year": "2011", "journal-title": "Cancer Res"}, {"key": "10.1002/pros.23263-BIB0006|pros23263-cit-0006", "doi-asserted-by": "crossref", "first-page": "314", "DOI": "10.1007/s12149-013-0687-7", "article-title": "Biological evaluation of 3-[(18)F]fluoro-\u03b1-methyl-D-tyrosine (D-[(18)F]FAMT) as a novel amino acid tracer for positron emission tomography", "volume": "27", "author": "Ohshima", "year": "2013", "journal-title": "Ann Nucl Med"}, {"key": "10.1002/pros.23263-BIB0007|pros23263-cit-0007", "doi-asserted-by": "crossref", "first-page": "509", "DOI": "10.1186/1471-2407-13-509", "article-title": "Increased expression of system large amino acid transporter (LAT)-1 mRNA is associated with invasive potential and unfavorable prognosis of human clear cell renal cell carcinoma", "volume": "13", "author": "Betsunoh", "year": "2013", "journal-title": "BMC Cancer"}, {"key": "10.1002/pros.23263-BIB0008|pros23263-cit-0008", "first-page": "885", "article-title": "Inhibition of system L (LAT1/CD98hc) reduces the growth of cultured human breast cancer cells", "volume": "20", "author": "Shennan", "year": "2008", "journal-title": "Oncol Rep"}, {"key": "10.1002/pros.23263-BIB0009|pros23263-cit-0009", "doi-asserted-by": "crossref", "first-page": "233", "DOI": "10.1002/jso.20257", "article-title": "Expression of L-type amino acid transporter 1 (LAT1) in esophageal carcinoma", "volume": "90", "author": "Kobayashi", "year": "2005", "journal-title": "J Surg Oncol"}, {"key": "10.1002/pros.23263-BIB0010|pros23263-cit-0010", "doi-asserted-by": "crossref", "first-page": "339", "DOI": "10.2174/1389200013338324", "article-title": "Heterodimeric amino acid transporters: Molecular biology and pathological and pharmacological relevance", "volume": "2", "author": "Kanai", "year": "2001", "journal-title": "Curr Drug Metab"}, {"key": "10.1002/pros.23263-BIB0011|pros23263-cit-0011", "doi-asserted-by": "crossref", "first-page": "23629", "DOI": "10.1074/jbc.273.37.23629", "article-title": "Expression cloning and characterization of a transporter for large neutral amino acids activated by the heavy chain of 4F2 antigen (CD98)", "volume": "273", "author": "Kanai", "year": "1998", "journal-title": "J Biol Chem"}, {"key": "10.1002/pros.23263-BIB0012|pros23263-cit-0012", "doi-asserted-by": "crossref", "first-page": "7", "DOI": "10.1111/j.1440-1827.2008.02319.x", "article-title": "L-type amino-acid transporter 1 as a novel biomarker for high-grade malignancy in prostate cancer", "volume": "59", "author": "Sakata", "year": "2009", "journal-title": "Pathol Int"}, {"key": "10.1002/pros.23263-BIB0013|pros23263-cit-0013", "doi-asserted-by": "crossref", "first-page": "274", "DOI": "10.3892/mco.2012.54", "article-title": "L-type amino acid transporter 1 expression is highly correlated with Gleason score in prostate cancer", "volume": "1", "author": "Segawa", "year": "2013", "journal-title": "Mol Clin Oncol"}, {"key": "10.1002/pros.23263-BIB0014|pros23263-cit-0014", "doi-asserted-by": "crossref", "first-page": "43838", "DOI": "10.1074/jbc.M305221200", "article-title": "Identification of a novel system L amino acid transporter structurally distinct from heterodimeric amino acid transporters", "volume": "278", "author": "Babu", "year": "2003", "journal-title": "J Biol Chem"}, {"issue": "19", "key": "10.1002/pros.23263-BIB0015|pros23263-cit-0015", "doi-asserted-by": "crossref", "first-page": "1463", "DOI": "10.1093/jnci/djt241", "article-title": "Targeting amino acid transport in metastatic castration-resistant prostate cancer: Effects on cell cycle, cell growth, and tumor development", "volume": "105", "author": "Wang", "year": "2013", "journal-title": "J Natl Cancer Inst"}, {"key": "10.1002/pros.23263-BIB0016|pros23263-cit-0016", "doi-asserted-by": "crossref", "first-page": "19745", "DOI": "10.1074/jbc.274.28.19745", "article-title": "Identification and functional characterization of a Na+-independent neutral amino acid transporter with broad substrate selectivity", "volume": "274", "author": "Segawa", "year": "1999", "journal-title": "J Biol Chem"}, {"key": "10.1002/pros.23263-BIB0017|pros23263-cit-0017", "doi-asserted-by": "crossref", "first-page": "293", "DOI": "10.1038/6809", "article-title": "Identification of SLC7A7, encoding y+LAT-1, as the lysinuric protein intolerance gene", "volume": "21", "author": "Torrents", "year": "1999", "journal-title": "Nat Genet"}, {"key": "10.1002/pros.23263-BIB0018|pros23263-cit-0018", "doi-asserted-by": "crossref", "first-page": "31830", "DOI": "10.1074/jbc.M111.229518", "article-title": "SLC6A14 (ATB0,+) protein, a highly concentrative and broad specific amino acid transporter, is a novel and effective drug target for treatment of estrogen receptor-positive breast cancer", "volume": "286", "author": "Karunakaran", "year": "2011", "journal-title": "J Biol Chem"}, {"issue": "Pt 1", "key": "10.1002/pros.23263-BIB0019|pros23263-cit-0019", "doi-asserted-by": "crossref", "first-page": "421", "DOI": "10.1042/BJ20051273", "article-title": "The orphan transporter v7-3 (slc6a15) is a Na+-dependent neutral amino acid transporter (B0AT2)", "volume": "393", "author": "Br\u00f6er", "year": "2006", "journal-title": "Biochem J"}, {"key": "10.1002/pros.23263-BIB0020|pros23263-cit-0020", "doi-asserted-by": "crossref", "first-page": "252", "DOI": "10.1016/j.neuron.2011.04.005", "article-title": "The neuronal transporter gene SLC6A15 confers risk to major depression", "volume": "70", "author": "Kohli", "year": "2011", "journal-title": "Neuron"}, {"key": "10.1002/pros.23263-BIB0021|pros23263-cit-0021", "doi-asserted-by": "crossref", "first-page": "1003", "DOI": "10.1038/ng1406", "article-title": "Hartnup disorder is caused by mutations in the gene encoding the neutral amino acid transporter SLC6A19", "volume": "36", "author": "Seow", "year": "2004", "journal-title": "Nat Genet"}, {"key": "10.1002/pros.23263-BIB0022|pros23263-cit-0022", "doi-asserted-by": "crossref", "first-page": "1316", "DOI": "10.1074/jbc.M210449200", "article-title": "Functional cooperation of epithelial heteromeric amino acid transporters expressed in madin-darby canine kidney cells", "volume": "278", "author": "Bauch", "year": "2003", "journal-title": "J Biol Chem"}, {"key": "10.1002/pros.23263-BIB0023|pros23263-cit-0023", "doi-asserted-by": "crossref", "first-page": "274", "DOI": "10.1002/ijc.2910210305", "article-title": "Isolation of a human prostate carcinoma cell line (DU 145)", "volume": "21", "author": "Stone", "year": "1978", "journal-title": "Int J Cancer"}, {"key": "10.1002/pros.23263-BIB0024|pros23263-cit-0024", "first-page": "16", "article-title": "Establishment and characterization of a human prostatic carcinoma cell line (PC-3)", "volume": "17", "author": "Kaighn", "year": "1979", "journal-title": "Invest Urol"}, {"key": "10.1002/pros.23263-BIB0025|pros23263-cit-0025", "doi-asserted-by": "crossref", "first-page": "5939", "DOI": "10.1074/jbc.273.10.5939", "article-title": "Expression of human prostatic acid phosphatase correlates with androgen-stimulated cell proliferation in prostate cancer cell lines", "volume": "273", "author": "Lin", "year": "1998", "journal-title": "J Biol Chem"}, {"key": "10.1002/pros.23263-BIB0026|pros23263-cit-0026", "first-page": "1809", "article-title": "LNCaP model of human prostatic carcinoma", "volume": "43", "author": "Horoszewicz", "year": "1983", "journal-title": "Cancer Res"}, {"key": "10.1002/pros.23263-BIB0027|pros23263-cit-0027", "first-page": "162", "article-title": "Ets-1 and hypoxia inducible factor-1alpha inhibition by angiotensin II type-1 receptor blockade in hormone-refractory prostate cancer", "volume": "70", "author": "Kosaka", "year": "2010", "journal-title": "Prostate"}, {"key": "10.1002/pros.23263-BIB0028|pros23263-cit-0028", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1016/S1476-5586(04)80047-2", "article-title": "ONCOMINE: A cancer microarray database and integrated data-mining platform", "volume": "6", "author": "Rhodes", "year": "2004", "journal-title": "Neoplasia"}, {"key": "10.1002/pros.23263-BIB0029|pros23263-cit-0029", "doi-asserted-by": "crossref", "first-page": "5117", "DOI": "10.1158/0008-5472.CAN-06-4040", "article-title": "Molecular features of hormone-refractory prostate cancer cells by genome-wide gene expression profiles", "volume": "67", "author": "Tamura", "year": "2007", "journal-title": "Cancer Res"}, {"issue": "19 Pt 1", "key": "10.1002/pros.23263-BIB0030|pros23263-cit-0030", "doi-asserted-by": "crossref", "first-page": "6823", "DOI": "10.1158/1078-0432.CCR-05-0585", "article-title": "Molecular alterations in primary prostate cancer after androgen ablation therapy", "volume": "11", "author": "Best", "year": "2005", "journal-title": "Clin Cancer Res"}, {"key": "10.1002/pros.23263-BIB0031|pros23263-cit-0031", "doi-asserted-by": "crossref", "first-page": "41", "DOI": "10.1038/ng1935", "article-title": "Integrative molecular concept modeling of prostate cancer progression", "volume": "39", "author": "Tomlins", "year": "2007", "journal-title": "Nat Genet"}, {"key": "10.1002/pros.23263-BIB0032|pros23263-cit-0032", "doi-asserted-by": "crossref", "first-page": "239", "DOI": "10.1038/nature11125", "article-title": "The mutational landscape of lethal castration-resistant prostate cancer", "volume": "487", "author": "Grasso", "year": "2012", "journal-title": "Nature"}, {"key": "10.1002/pros.23263-BIB0033|pros23263-cit-0033", "doi-asserted-by": "crossref", "first-page": "811", "DOI": "10.1073/pnas.0304146101", "article-title": "Gene expression profiling identifies clinically relevant subtypes of prostate cancer", "volume": "101", "author": "Lapointe", "year": "2004", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "10.1002/pros.23263-BIB0034|pros23263-cit-0034", "doi-asserted-by": "crossref", "first-page": "217", "DOI": "10.1016/S0002-9440(10)63112-4", "article-title": "Gene expression analysis of human prostate carcinoma during hormonal therapy identifies androgen-responsive genes and mechanisms of therapy resistance", "volume": "164", "author": "Holzbeierlein", "year": "2004", "journal-title": "Am J Pathol"}, {"key": "10.1002/pros.23263-BIB0035|pros23263-cit-0035", "first-page": "3877", "article-title": "Transcriptional silencing of zinc finger protein 185 identified by expression profiling is associated with prostate cancer progression", "volume": "63", "author": "Vanaja", "year": "2003", "journal-title": "Cancer Res"}, {"key": "10.1002/pros.23263-BIB0036|pros23263-cit-0036", "first-page": "4499", "article-title": "Comprehensive gene expression analysis of prostate cancer reveals distinct transcriptional programs associated with metastatic disease", "volume": "62", "author": "LaTulippe", "year": "2002", "journal-title": "Cancer Res"}, {"key": "10.1002/pros.23263-BIB0037|pros23263-cit-0037", "doi-asserted-by": "crossref", "first-page": "43", "DOI": "10.1152/physrev.1990.70.1.43", "article-title": "Role of amino acid transport and countertransport in nutrition and metabolism", "volume": "70", "author": "Christensen", "year": "1990", "journal-title": "Physiol Rev"}, {"key": "10.1002/pros.23263-BIB0038|pros23263-cit-0038", "doi-asserted-by": "crossref", "first-page": "1369", "DOI": "10.1021/cb500120x", "article-title": "Monoterpene glycoside ESK246 from Pittosporum targets LAT3 amino acid transport and prostate cancer cell growth", "volume": "9", "author": "Wang", "year": "2014", "journal-title": "ACS Chem Biol"}, {"key": "10.1002/pros.23263-BIB0039|pros23263-cit-0039", "doi-asserted-by": "crossref", "first-page": "570", "DOI": "10.1038/nature11005", "article-title": "Systematic identification of genomic markers of drug sensitivity in cancer cells", "volume": "483", "author": "Garnett", "year": "2012", "journal-title": "Nature"}], "container-title": ["The Prostate"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fpros.23263", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fpros.23263", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://onlinelibrary.wiley.com/wol1/doi/10.1002/pros.23263/fullpdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 9, 14]], "date-time": "2019-09-14T10:50:16Z", "timestamp": 1568458216000}, "score": 27.668541, "subtitle": ["Leucine Transporter Change in Prostate Cancer"], "issued": {"date-parts": [[2016, 10, 3]]}, "references-count": 39, "journal-issue": {"published-print": {"date-parts": [[2017, 2]]}, "issue": "2"}, "URL": "http://dx.doi.org/10.1002/pros.23263", "archive": ["Portico"], "relation": {"cites": []}, "ISSN": ["0270-4137"], "issn-type": [{"value": "0270-4137", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 12, 4]], "date-time": "2019-12-04T11:20:46Z", "timestamp": 1575458446119}, "reference-count": 0, "publisher": "Ovid Technologies (Wolters Kluwer Health)", "issue": "4S", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2014, 4, 1]], "date-time": "2014-04-01T00:00:00Z", "timestamp": 1396310400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Journal of Urology"], "published-print": {"date-parts": [[2014, 4]]}, "DOI": "10.1016/j.juro.2014.02.917", "type": "journal-article", "created": {"date-parts": [[2014, 3, 28]], "date-time": "2014-03-28T19:38:01Z", "timestamp": 1396035481000}, "source": "Crossref", "is-referenced-by-count": 0, "title": ["MP31-08 SEMENOGELIN I PROMOTES PROSTATE CANCER CELL GROWTH VIA FUNCTIONING AS AN ANDROGEN RECEPTOR COACTIVATOR AND PROTECTING AGAINST ZINC CYTOTOXICITY"], "prefix": "10.1097", "volume": "191", "author": [{"given": "Hitoshi", "family": "Ishiguro", "sequence": "first", "affiliation": [{"name": "Baltimore, MD"}]}, {"given": "Koji", "family": "Izumi", "sequence": "additional", "affiliation": [{"name": "Rochester, NY"}]}, {"given": "Yi", "family": "Li", "sequence": "additional", "affiliation": [{"name": "Rochester, NY"}]}, {"given": "Yichun", "family": "Zheng", "sequence": "additional", "affiliation": [{"name": "Baltimore, MD"}]}, {"given": "Eiji", "family": "Kashiwagi", "sequence": "additional", "affiliation": [{"name": "Baltimore, MD"}]}, {"given": "Takashi", "family": "Kawahara", "sequence": "additional", "affiliation": [{"name": "Baltimore, MD"}]}, {"given": "Hiroshi", "family": "Miyamoto", "sequence": "additional", "affiliation": [{"name": "Baltimore, MD"}]}], "member": "276", "container-title": ["Journal of Urology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0022534714011756?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0022534714011756?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 6, 17]], "date-time": "2019-06-17T16:01:01Z", "timestamp": 1560787261000}, "score": 27.585972, "issued": {"date-parts": [[2014, 4]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2014, 4]]}, "issue": "4S"}, "alternative-id": ["10.1016/j.juro.2014.02.917"], "URL": "http://dx.doi.org/10.1016/j.juro.2014.02.917", "ISSN": ["0022-5347", "1527-3792"], "issn-type": [{"value": "0022-5347", "type": "print"}, {"value": "1527-3792", "type": "electronic"}], "subject": ["Urology"]}, {"indexed": {"date-parts": [[2019, 12, 2]], "date-time": "2019-12-02T03:00:22Z", "timestamp": 1575255622836}, "reference-count": 136, "publisher": "MDPI AG", "issue": "8", "license": [{"URL": "https://creativecommons.org/licenses/by/4.0/", "start": {"date-parts": [[2013, 7, 26]], "date-time": "2013-07-26T00:00:00Z", "timestamp": 1374796800000}, "delay-in-days": 0, "content-version": "unspecified"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["IJMS"], "DOI": "10.3390/ijms140815615", "type": "journal-article", "created": {"date-parts": [[2013, 7, 27]], "date-time": "2013-07-27T02:13:15Z", "timestamp": 1374891195000}, "page": "15615-15635", "source": "Crossref", "is-referenced-by-count": 17, "title": ["Experimental Evidence of Persistent  Androgen-Receptor-Dependency in Castration-Resistant Prostate Cancer"], "prefix": "10.3390", "volume": "14", "author": [{"given": "Takashi", "family": "Kobayashi", "sequence": "first", "affiliation": []}, {"given": "Takahiro", "family": "Inoue", "sequence": "additional", "affiliation": []}, {"given": "Tomomi", "family": "Kamba", "sequence": "additional", "affiliation": []}, {"given": "Osamu", "family": "Ogawa", "sequence": "additional", "affiliation": []}], "member": "1968", "published-online": {"date-parts": [[2013, 7, 26]]}, "reference": [{"key": "ref1", "doi-asserted-by": "crossref", "first-page": "1513", "DOI": "10.1056/NEJMoa041318", "article-title": "Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer", "volume": "351", "author": "Petrylak", "year": "2004", "journal-title": "N. Engl. J. Med."}, {"key": "ref2", "doi-asserted-by": "crossref", "first-page": "1502", "DOI": "10.1056/NEJMoa040720", "article-title": "Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer", "volume": "351", "author": "Tannock", "year": "2004", "journal-title": "N. Engl. J. Med"}, {"key": "ref3", "doi-asserted-by": "crossref", "first-page": "459", "DOI": "10.1677/erc.1.00525", "article-title": "Targeting the androgen receptor: Improving outcomes for castration-resistant prostate cancer", "volume": "11", "author": "Scher", "year": "2004", "journal-title": "Endocr. Relat. Cancer"}, {"key": "ref4", "doi-asserted-by": "crossref", "first-page": "8253", "DOI": "10.1200/JCO.2005.03.4777", "article-title": "Biology of progressive, castration-resistant prostate cancer: Directed therapies targeting the androgen-receptor signaling axis", "volume": "23", "author": "Scher", "year": "2005", "journal-title": "J. Clin. Oncol"}, {"key": "ref5", "doi-asserted-by": "crossref", "first-page": "1187", "DOI": "10.1056/NEJMoa1207506", "article-title": "Increased survival with enzalutamide in prostate cancer after chemotherapy", "volume": "367", "author": "Scher", "year": "2012", "journal-title": "N. Engl. J. Med"}, {"key": "ref6", "doi-asserted-by": "crossref", "first-page": "983", "DOI": "10.1016/S1470-2045(12)70379-0", "article-title": "Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: Final overall survival analysis of the cou-aa-301 randomised, double-blind, placebo-controlled phase 3 study", "volume": "13", "author": "Fizazi", "year": "2012", "journal-title": "Lancet Oncol"}, {"key": "ref7", "first-page": "6940", "article-title": "Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer", "volume": "52", "author": "McDonnell", "year": "1992", "journal-title": "Cancer Res"}, {"key": "ref8", "doi-asserted-by": "crossref", "first-page": "179", "DOI": "10.1002/pros.10047", "article-title": "Clusterin expression is significantly enhanced in prostate cancer cells following androgen withdrawal therapy", "volume": "50", "author": "July", "year": "2002", "journal-title": "Prostate"}, {"key": "ref9", "doi-asserted-by": "crossref", "first-page": "363", "DOI": "10.1002/jcb.22022", "article-title": "Mechanisms of prostate cancer cell survival after inhibition of ar expression", "volume": "106", "author": "Cohen", "year": "2009", "journal-title": "J. Cell. Biochem"}, {"key": "ref10", "doi-asserted-by": "crossref", "first-page": "1300", "DOI": "10.1111/j.1464-410X.2006.06147.x", "article-title": "Induction of apoptosis and enhancement of chemosensitivity in human prostate cancer lncap cells using bispecific antisense oligonucleotide targeting bcl-2 and bcl-xl genes", "volume": "97", "author": "Yamanaka", "year": "2006", "journal-title": "BJU Int"}, {"key": "ref11", "doi-asserted-by": "crossref", "first-page": "4483", "DOI": "10.1158/0008-5472.CAN-12-0283", "article-title": "Dual targeting of the akt/mtor signaling pathway inhibits castration-resistant prostate cancer in a genetically engineered mouse model", "volume": "72", "author": "Floc\u2019h", "year": "2012", "journal-title": "Cancer Res"}, {"key": "ref12", "doi-asserted-by": "crossref", "first-page": "263", "DOI": "10.1016/S0094-0143(05)70066-5", "article-title": "The biology of hormone refractory prostate cancer. Why does it develop?", "volume": "26", "author": "Isaacs", "year": "1999", "journal-title": "Urol. Clin. North Am"}, {"key": "ref13", "doi-asserted-by": "crossref", "first-page": "495", "DOI": "10.1038/nature08361", "article-title": "A luminal epithelial stem cell that is a cell of origin for prostate cancer", "volume": "461", "author": "Wang", "year": "2009", "journal-title": "Nature"}, {"key": "ref14", "doi-asserted-by": "crossref", "first-page": "725", "DOI": "10.1016/j.eururo.2006.11.043", "article-title": "Cellular changes in prostate cancer cells induced by intermittent androgen suppression", "volume": "52", "author": "Laitinen", "year": "2007", "journal-title": "Eur. Urol"}, {"key": "ref15", "doi-asserted-by": "crossref", "first-page": "217", "DOI": "10.1016/S0002-9440(10)63112-4", "article-title": "Gene expression analysis of human prostate carcinoma during hormonal therapy identifies androgen-responsive genes and mechanisms of therapy resistance", "volume": "164", "author": "Holzbeierlein", "year": "2004", "journal-title": "Am. J. Pathol"}, {"key": "ref16", "doi-asserted-by": "crossref", "first-page": "2815", "DOI": "10.1158/0008-5472.CAN-05-4000", "article-title": "Increased expression of genes converting adrenal androgens to testosterone in androgen-independent prostate cancer", "volume": "66", "author": "Stanbrough", "year": "2006", "journal-title": "Cancer Res"}, {"key": "ref17", "doi-asserted-by": "crossref", "first-page": "6142", "DOI": "10.1158/0008-5472.CAN-12-1335", "article-title": "Distinct patterns of dysregulated expression of enzymes involved in androgen synthesis and metabolism in metastatic prostate cancer tumors", "volume": "72", "author": "Mitsiades", "year": "2012", "journal-title": "Cancer Res"}, {"key": "ref18", "doi-asserted-by": "crossref", "first-page": "6407", "DOI": "10.1158/0008-5472.CAN-07-5997", "article-title": "Androgen levels increase by intratumoral de novo steroidogenesis during progression of castration-resistant prostate cancer", "volume": "68", "author": "Locke", "year": "2008", "journal-title": "Cancer Res"}, {"key": "ref19", "doi-asserted-by": "crossref", "first-page": "4447", "DOI": "10.1158/0008-5472.CAN-08-0249", "article-title": "Maintenance of intratumoral androgens in metastatic prostate cancer: A mechanism for castration-resistant tumor growth", "volume": "68", "author": "Montgomery", "year": "2008", "journal-title": "Cancer Res"}, {"key": "ref20", "unstructured": "http://clinicaltrials.gov/ct2/home"}, {"key": "ref21", "first-page": "735", "article-title": "Androgen receptor status in localized and locally progressive hormone refractory human prostate cancer", "volume": "144", "author": "Ruizeveld de Winter", "year": "1994", "journal-title": "Am. J. Pathol"}, {"key": "ref22", "first-page": "1566", "article-title": "Increased androgen receptor activity and altered c-myc expression in prostate cancer cells after long-term androgen deprivation", "volume": "54", "author": "Kokontis", "year": "1994", "journal-title": "Cancer Res"}, {"key": "ref23", "doi-asserted-by": "crossref", "first-page": "401", "DOI": "10.1038/ng0495-401", "article-title": "In vivo amplification of the androgen receptor gene and progression of human prostate cancer", "volume": "9", "author": "Visakorpi", "year": "1995", "journal-title": "Nat. Genet"}, {"key": "ref24", "first-page": "1608", "article-title": "Analysis of genetic changes underlying local recurrence of prostate carcinoma during androgen deprivation therapy", "volume": "147", "author": "Koivisto", "year": "1995", "journal-title": "Am. J. Pathol"}, {"key": "ref25", "first-page": "3068", "article-title": "Distant metastases from prostatic carcinoma express androgen receptor protein", "volume": "55", "author": "Hobisch", "year": "1995", "journal-title": "Cancer Res"}, {"key": "ref26", "doi-asserted-by": "crossref", "first-page": "1992", "DOI": "10.1016/S0022-5347(05)66935-2", "article-title": "Androgen receptor gene amplification at primary progression predicts response to combined androgen blockade as second line therapy for advanced prostate cancer", "volume": "164", "author": "Palmberg", "year": "2000", "journal-title": "J. Urol"}, {"key": "ref27", "doi-asserted-by": "crossref", "first-page": "1455", "DOI": "10.1038/labinvest.3780152", "article-title": "Fish analysis of gene aberrations (myc, ccnd1, erbb2, rb, and ar) in advanced prostatic carcinomas before and after androgen deprivation therapy", "volume": "80", "author": "Kaltz-Wittmer", "year": "2000", "journal-title": "Lab. Invest"}, {"key": "ref28", "first-page": "1919", "article-title": "Evaluation of androgen, estrogen (er alpha and er beta), and progesterone receptor expression in human prostate cancer by real-time quantitative reverse transcription-polymerase chain reaction assays", "volume": "61", "author": "Latil", "year": "2001", "journal-title": "Cancer Res"}, {"key": "ref29", "first-page": "3550", "article-title": "Amplification and overexpression of androgen receptor gene in hormone-refractory prostate cancer", "volume": "61", "author": "Linja", "year": "2001", "journal-title": "Cancer Res"}, {"key": "ref30", "doi-asserted-by": "crossref", "first-page": "552", "DOI": "10.1038/sj.bjc.6601127", "article-title": "Androgen receptor gene amplification and protein expression in hormone refractory prostate cancer", "volume": "89", "author": "Edwards", "year": "2003", "journal-title": "Br. J. Cancer"}, {"key": "ref31", "doi-asserted-by": "crossref", "first-page": "1817", "DOI": "10.1097/01.ju.0000091873.09677.f4", "article-title": "Androgen receptor gene amplification and protein expression in recurrent prostate cancer", "volume": "170", "author": "Ford", "year": "2003", "journal-title": "J. Urol."}, {"key": "ref32", "doi-asserted-by": "crossref", "first-page": "474", "DOI": "10.1016/j.humpath.2006.09.008", "article-title": "Androgen receptor amplification is associated with increased cell proliferation in prostate cancer", "volume": "38", "author": "Haapala", "year": "2007", "journal-title": "Hum. Pathol"}, {"key": "ref33", "doi-asserted-by": "crossref", "first-page": "11", "DOI": "10.1016/j.ccr.2010.05.026", "article-title": "Integrative genomic profiling of human prostate cancer", "volume": "18", "author": "Taylor", "year": "2010", "journal-title": "Cancer Cell"}, {"key": "ref34", "doi-asserted-by": "crossref", "first-page": "462", "DOI": "10.1111/j.1464-410X.2009.08747.x", "article-title": "Androgen receptor expression is associated with prostate cancer-specific survival in castrate patients with metastatic disease", "volume": "105", "author": "Donovan", "year": "2010", "journal-title": "BJU Int"}, {"key": "ref35", "doi-asserted-by": "crossref", "first-page": "616", "DOI": "10.1158/0008-5472.CAN-11-2079", "article-title": "Common structural and epigenetic changes in the genome of castration-resistant prostate cancer", "volume": "72", "author": "Friedlander", "year": "2012", "journal-title": "Cancer Res"}, {"key": "ref36", "doi-asserted-by": "crossref", "first-page": "2091", "DOI": "10.1158/1078-0432.CCR-08-2036", "article-title": "Fluorescence in situ hybridization analysis of circulating tumor cells in metastatic prostate cancer", "volume": "15", "author": "Leversha", "year": "2009", "journal-title": "Clin. Cancer Res"}, {"key": "ref37", "doi-asserted-by": "crossref", "first-page": "2912", "DOI": "10.1158/0008-5472.CAN-08-3667", "article-title": "Characterization of erg, ar and pten gene status in circulating tumor cells from patients with castration-resistant prostate cancer", "volume": "69", "author": "Attard", "year": "2009", "journal-title": "Cancer Res"}, {"key": "ref38", "doi-asserted-by": "crossref", "first-page": "78", "DOI": "10.1186/1471-2407-12-78", "article-title": "Isolation and genomic analysis of circulating tumor cells from castration resistant metastatic prostate cancer", "volume": "12", "author": "Magbanua", "year": "2012", "journal-title": "BMC Cancer"}, {"key": "ref39", "doi-asserted-by": "crossref", "first-page": "245", "DOI": "10.1016/j.eururo.2005.12.035", "article-title": "The human pc346 xenograft and cell line panel: A model system for prostate cancer progression", "volume": "49", "author": "Marques", "year": "2006", "journal-title": "Eur. Urol"}, {"key": "ref40", "doi-asserted-by": "crossref", "first-page": "33", "DOI": "10.1038/nm972", "article-title": "Molecular determinants of resistance to antiandrogen therapy", "volume": "10", "author": "Chen", "year": "2004", "journal-title": "Nat. Med"}, {"key": "ref41", "doi-asserted-by": "crossref", "first-page": "9111", "DOI": "10.1038/sj.onc.1208154", "article-title": "Molecular analysis integrating different pathways associated with androgen-independent progression in lucap 23.1 xenograft", "volume": "23", "author": "Rocchi", "year": "2004", "journal-title": "Oncogene"}, {"key": "ref42", "doi-asserted-by": "crossref", "first-page": "9611", "DOI": "10.1158/0008-5472.CAN-05-0817", "article-title": "Antiandrogen bicalutamide promotes tumor growth in a novel androgen-dependent prostate cancer xenograft model derived from a bicalutamide-treated patient", "volume": "65", "author": "Yoshida", "year": "2005", "journal-title": "Cancer Res"}, {"key": "ref43", "doi-asserted-by": "crossref", "first-page": "1606", "DOI": "10.1158/0008-5472.CAN-09-2984", "article-title": "Identification of ep4 as a potential target for the treatment of castration-resistant prostate cancer using a novel xenograft model", "volume": "70", "author": "Terada", "year": "2010", "journal-title": "Cancer Res"}, {"key": "ref44", "doi-asserted-by": "crossref", "first-page": "8141", "DOI": "10.1158/0008-5472.CAN-09-0919", "article-title": "Increased expression of androgen receptor sensitizes prostate cancer cells to low levels of androgens", "volume": "69", "author": "Waltering", "year": "2009", "journal-title": "Cancer Res"}, {"key": "ref45", "first-page": "314", "article-title": "Androgen receptor gene amplification: A possible molecular mechanism for androgen deprivation therapy failure in prostate cancer", "volume": "57", "author": "Koivisto", "year": "1997", "journal-title": "Cancer Res"}, {"key": "ref46", "first-page": "803", "article-title": "Survey of gene amplifications during prostate cancer progression by high-throughout fluorescence in situ hybridization on tissue microarrays", "volume": "59", "author": "Bubendorf", "year": "1999", "journal-title": "Cancer Res"}, {"key": "ref47", "doi-asserted-by": "crossref", "first-page": "R25", "DOI": "10.1530/JME-11-0018", "article-title": "Increased androgen receptor transcription: A cause of castration-resistant prostate cancer and a possible therapeutic target", "volume": "47", "author": "Shiota", "year": "2011", "journal-title": "J. Mol. Endocrinol"}, {"key": "ref48", "doi-asserted-by": "crossref", "first-page": "3282", "DOI": "10.1210/endo.140.7.6769", "article-title": "Differential posttranscriptional regulation of androgen receptor gene expression by androgen in prostate and breast cancer cells", "volume": "140", "author": "Yeap", "year": "1999", "journal-title": "Endocrinology"}, {"key": "ref49", "doi-asserted-by": "crossref", "first-page": "27183", "DOI": "10.1074/jbc.M202883200", "article-title": "Novel binding of hur and poly(c)-binding protein to a conserved uc-rich motif within the 3\u2032-untranslated region of the androgen receptor messenger rna", "volume": "277", "author": "Yeap", "year": "2002", "journal-title": "J. Biol. Chem"}, {"key": "ref50", "doi-asserted-by": "crossref", "first-page": "3619", "DOI": "10.1093/nar/gkq084", "article-title": "Post-transcriptional regulation of androgen receptor mrna by an erbb3 binding protein 1 in prostate cancer", "volume": "38", "author": "Zhou", "year": "2010", "journal-title": "Nucleic Acids Res"}, {"key": "ref51", "first-page": "107", "article-title": "Micrornas and androgen receptor 3\u2032 untranslated region: A missing link in castration-resistant prostate cancer?", "volume": "3", "author": "Sikand", "year": "2011", "journal-title": "Mol. Cell. Pharmacol"}, {"key": "ref52", "doi-asserted-by": "crossref", "first-page": "1956", "DOI": "10.1158/0008-5472.CAN-10-2421", "article-title": "Systematic analysis of micrornas targeting the androgen receptor in prostate cancer cells", "volume": "71", "author": "Ostling", "year": "2011", "journal-title": "Cancer Res"}, {"key": "ref53", "doi-asserted-by": "crossref", "first-page": "810", "DOI": "10.1002/ijc.25753", "article-title": "Mir 488* inhibits androgen receptor expression in prostate carcinoma cells", "volume": "129", "author": "Sikand", "year": "2011", "journal-title": "Int. J. Cancer"}, {"key": "ref54", "first-page": "2892", "article-title": "Androgen receptor stabilization in recurrent prostate cancer is associated with hypersensitivity to low androgen", "volume": "61", "author": "Gregory", "year": "2001", "journal-title": "Cancer Res."}, {"key": "ref55", "doi-asserted-by": "crossref", "first-page": "647", "DOI": "10.4161/cc.6.6.4028", "article-title": "Stabilizing androgen receptor in mitosis inhibits prostate cancer proliferation", "volume": "6", "author": "Vander Griend", "year": "2007", "journal-title": "Cell Cycle"}, {"key": "ref56", "first-page": "701", "article-title": "Stabilization of androgen receptor by nonandrogenic steroids", "volume": "12", "author": "Nemoto", "year": "1986", "journal-title": "Biochem. Int"}, {"key": "ref57", "first-page": "208", "article-title": "Specificity of ligand-dependent androgen receptor stabilization: Receptor domain interactions influence ligand dissociation and receptor stability", "volume": "9", "author": "Zhou", "year": "1995", "journal-title": "Mol. Endocrinol"}, {"key": "ref58", "doi-asserted-by": "crossref", "first-page": "157", "DOI": "10.1016/S0090-4295(96)00117-3", "article-title": "Agonist and antagonist activities of hydroxyflutamide and casodex relate to androgen receptor stabilization", "volume": "48", "author": "Kemppainen", "year": "1996", "journal-title": "Urology"}, {"key": "ref59", "doi-asserted-by": "crossref", "first-page": "779", "DOI": "10.1016/S0006-291X(02)00564-8", "article-title": "Stabilization of androgen receptor protein is induced by agonist, not by antagonists", "volume": "294", "author": "Furutani", "year": "2002", "journal-title": "Biochem. Biophys. Res. Commun"}, {"key": "ref60", "doi-asserted-by": "crossref", "first-page": "1247", "DOI": "10.1016/j.fertnstert.2010.11.012", "article-title": "Testosterone dependent androgen receptor stabilization and activation of cell proliferation in primary human myometrial microvascular endothelial cells", "volume": "95", "author": "Dietrich", "year": "2011", "journal-title": "Fertil. Steril"}, {"key": "ref61", "doi-asserted-by": "crossref", "first-page": "3053", "DOI": "10.1210/me.2006-0033", "article-title": "Requirement of androgen-dependent activation of protein kinase czeta for androgen-dependent cell proliferation in lncap cells and its roles in transition to androgen-independent cells", "volume": "20", "author": "Inoue", "year": "2006", "journal-title": "Mol. Endocrinol"}, {"key": "ref62", "doi-asserted-by": "crossref", "first-page": "347", "DOI": "10.1158/1535-7163.MCT-10-0850", "article-title": "Transcription factor stat5 knockdown enhances androgen receptor degradation and delays castration-resistant prostate cancer progression in vivo", "volume": "10", "author": "Thomas", "year": "2011", "journal-title": "Mol. Cancer Ther"}, {"key": "ref63", "doi-asserted-by": "crossref", "first-page": "15969", "DOI": "10.1073/pnas.0604193103", "article-title": "Androgen receptor phosphorylation and stabilization in prostate cancer by cyclin-dependent kinase 1", "volume": "103", "author": "Chen", "year": "2006", "journal-title": "Proc. Natl. Acad. Sci. USA"}, {"key": "ref64", "doi-asserted-by": "crossref", "first-page": "33141", "DOI": "10.1074/jbc.M111.252080", "article-title": "Regulation of androgen receptor and prostate cancer growth by cyclin-dependent kinase 5", "volume": "286", "author": "Hsu", "year": "2011", "journal-title": "J. Biol. Chem"}, {"key": "ref65", "doi-asserted-by": "crossref", "first-page": "607", "DOI": "10.1016/S0022-5347(17)36163-3", "article-title": "Prostate specific antigen decline after antiandrogen withdrawal: The flutamide withdrawal syndrome", "volume": "149", "author": "Kelly", "year": "1993", "journal-title": "J. Urol"}, {"key": "ref66", "doi-asserted-by": "crossref", "first-page": "534", "DOI": "10.1016/S0006-291X(05)80067-1", "article-title": "A mutation in the ligand binding domain of the androgen receptor of human lncap cells affects steroid binding characteristics and response to anti-androgens", "volume": "173", "author": "Veldscholte", "year": "1990", "journal-title": "Biochem. Biophys. Res. Commun"}, {"key": "ref67", "first-page": "149", "article-title": "Novel mutations of androgen receptor: A possible mechanism of bicalutamide withdrawal syndrome", "volume": "63", "author": "Hara", "year": "2003", "journal-title": "Cancer Res"}, {"key": "ref68", "first-page": "252", "article-title": "Antiandrogen withdrawal syndrome and alternative antiandrogen therapy associated with the w741c mutant androgen receptor in a novel prostate cancer xenograft", "volume": "70", "author": "Terada", "year": "2010", "journal-title": "Prostate"}, {"key": "ref69", "first-page": "2861", "article-title": "Frequent detection of codon 877 mutation in the androgen receptor gene in advanced prostate cancers", "volume": "54", "author": "Gaddipati", "year": "1994", "journal-title": "Cancer Res"}, {"key": "ref70", "doi-asserted-by": "crossref", "first-page": "1393", "DOI": "10.1056/NEJM199505253322101", "article-title": "Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer", "volume": "332", "author": "Taplin", "year": "1995", "journal-title": "N. Engl. J. Med"}, {"key": "ref71", "doi-asserted-by": "crossref", "first-page": "255", "DOI": "10.1016/j.jsbmb.2004.10.012", "article-title": "Alterations of androgen receptor in prostate cancer", "volume": "92", "author": "Linja", "year": "2004", "journal-title": "J. Steroid. Biochem. Mol. Biol"}, {"key": "ref72", "doi-asserted-by": "crossref", "first-page": "920", "DOI": "10.1016/j.eururo.2012.08.053", "article-title": "Targeted next-generation sequencing of advanced prostate cancer identifies potential therapeutic targets and disease heterogeneity", "volume": "63", "author": "Beltran", "year": "2013", "journal-title": "Eur. Urol"}, {"key": "ref73", "doi-asserted-by": "crossref", "first-page": "34", "DOI": "10.1038/35094009", "article-title": "The development of androgen-independent prostate cancer", "volume": "1", "author": "Feldman", "year": "2001", "journal-title": "Nat. Rev. Cancer"}, {"key": "ref74", "doi-asserted-by": "crossref", "first-page": "175", "DOI": "10.1210/edrv.23.2.0460", "article-title": "Androgen receptor (ar) coregulators: An overview", "volume": "23", "author": "Heinlein", "year": "2002", "journal-title": "Endocr. Rev"}, {"key": "ref75", "doi-asserted-by": "crossref", "first-page": "1032", "DOI": "10.1158/1078-0432.CCR-0990-3", "article-title": "Expression of androgen receptor coregulators in prostate cancer", "volume": "10", "author": "Linja", "year": "2004", "journal-title": "Clin. Cancer Res"}, {"key": "ref76", "doi-asserted-by": "crossref", "first-page": "719", "DOI": "10.1002/ijc.22365", "article-title": "Androgen receptor coregulators and their involvement in the development and progression of prostate cancer", "volume": "120", "author": "Chmelar", "year": "2007", "journal-title": "Int. J. Cancer"}, {"key": "ref77", "first-page": "4315", "article-title": "A mechanism for androgen receptor-mediated prostate cancer recurrence after androgen deprivation therapy", "volume": "61", "author": "Gregory", "year": "2001", "journal-title": "Cancer Res"}, {"key": "ref78", "doi-asserted-by": "crossref", "first-page": "77", "DOI": "10.1196/annals.1336.009", "article-title": "Foxa1 and foxa2 interact with the androgen receptor to regulate prostate and epididymal genes differentially", "volume": "1061", "author": "Yu", "year": "2005", "journal-title": "Ann. N. Y. Acad. Sci"}, {"key": "ref79", "doi-asserted-by": "crossref", "first-page": "47", "DOI": "10.1101/gr.107961.110", "article-title": "Copy number and targeted mutational analysis reveals novel somatic events in metastatic prostate tumors", "volume": "21", "author": "Robbins", "year": "2011", "journal-title": "Genome Res"}, {"key": "ref80", "doi-asserted-by": "crossref", "first-page": "848", "DOI": "10.1016/j.ajpath.2011.10.021", "article-title": "Foxa1 promotes tumor progression in prostate cancer and represents a novel hallmark of castration-resistant prostate cancer", "volume": "180", "author": "Gerhardt", "year": "2012", "journal-title": "Am. J. Pathol"}, {"key": "ref81", "doi-asserted-by": "crossref", "first-page": "766", "DOI": "10.1111/j.1365-2559.2011.03796.x", "article-title": "High-level expression of forkhead-box protein a1 in metastatic prostate cancer", "volume": "58", "author": "Jain", "year": "2011", "journal-title": "Histopathology"}, {"key": "ref82", "doi-asserted-by": "crossref", "first-page": "245", "DOI": "10.1016/j.cell.2009.04.056", "article-title": "Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer", "volume": "138", "author": "Wang", "year": "2009", "journal-title": "Cell"}, {"key": "ref83", "doi-asserted-by": "crossref", "first-page": "3725", "DOI": "10.1158/0008-5472.CAN-12-3468", "article-title": "Androgen receptor-independent function of foxa1 in prostate cancer metastasis", "volume": "73", "author": "Jin", "year": "2013", "journal-title": "Cancer Res"}, {"key": "ref84", "doi-asserted-by": "crossref", "first-page": "1570", "DOI": "10.1158/0008-5472.CAN-12-2350", "article-title": "Foxa1 specifies unique androgen and glucocorticoid receptor binding events in prostate cancer cells", "volume": "73", "author": "Sahu", "year": "2013", "journal-title": "Cancer Res"}, {"key": "ref85", "doi-asserted-by": "crossref", "first-page": "6738", "DOI": "10.1158/0008-5472.CAN-11-1882", "article-title": "Definition of a foxa1 cistrome that is crucial for g1 to s-phase cell-cycle transit in castration-resistant prostate cancer", "volume": "71", "author": "Zhang", "year": "2011", "journal-title": "Cancer Res"}, {"key": "ref86", "doi-asserted-by": "crossref", "first-page": "941", "DOI": "10.1128/MCB.06306-11", "article-title": "Critical and reciprocal regulation of klf4 and slug in transforming growth factor beta-initiated prostate cancer epithelial-mesenchymal transition", "volume": "32", "author": "Liu", "year": "2012", "journal-title": "Mol. Cell. Biol"}, {"key": "ref87", "doi-asserted-by": "crossref", "first-page": "685", "DOI": "10.1038/ng.2279", "article-title": "Exome sequencing identifies recurrent spop, foxa1 and med12 mutations in prostate cancer", "volume": "44", "author": "Barbieri", "year": "2012", "journal-title": "Nat. Genet"}, {"key": "ref88", "doi-asserted-by": "crossref", "first-page": "239", "DOI": "10.1038/nature11125", "article-title": "The mutational landscape of lethal castration-resistant prostate cancer", "volume": "487", "author": "Grasso", "year": "2012", "journal-title": "Nature"}, {"key": "ref89", "doi-asserted-by": "crossref", "first-page": "221", "DOI": "10.1530/JOE-12-0238", "article-title": "Regulation of the androgen receptor by post-translational modifications", "volume": "215", "author": "Coffey", "year": "2012", "journal-title": "J. Endocrinol"}, {"key": "ref90", "doi-asserted-by": "crossref", "first-page": "70", "DOI": "10.1016/j.mce.2011.07.004", "article-title": "Post-translational modification of the androgen receptor", "volume": "352", "author": "Gioeli", "year": "2012", "journal-title": "Mol. Cell. Endocrinol"}, {"key": "ref91", "first-page": "5474", "article-title": "Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-i, keratinocyte growth factor, and epidermal growth factor", "volume": "54", "author": "Culig", "year": "1994", "journal-title": "Cancer Res"}, {"key": "ref92", "doi-asserted-by": "crossref", "first-page": "280", "DOI": "10.1038/6495", "article-title": "A mechanism for hormone-independent prostate cancer through modulation of androgen receptor signaling by the her-2/neu tyrosine kinase", "volume": "5", "author": "Craft", "year": "1999", "journal-title": "Nat. Med"}, {"key": "ref93", "doi-asserted-by": "crossref", "first-page": "e38950", "DOI": "10.1371/journal.pone.0038950", "article-title": "Identification of kinases regulating prostate cancer cell growth using an rnai phenotypic screen", "volume": "7", "author": "Whitworth", "year": "2012", "journal-title": "PLoS One"}, {"key": "ref94", "doi-asserted-by": "crossref", "first-page": "19900", "DOI": "10.1074/jbc.271.33.19900", "article-title": "Activation of the human androgen receptor through a protein kinase a signaling pathway", "volume": "271", "author": "Nazareth", "year": "1996", "journal-title": "J. Biol. Chem"}, {"key": "ref95", "doi-asserted-by": "crossref", "first-page": "8438", "DOI": "10.1073/pnas.0700420104", "article-title": "Activated cdc42-associated kinase ack1 promotes prostate cancer progression via androgen receptor tyrosine phosphorylation", "volume": "104", "author": "Mahajan", "year": "2007", "journal-title": "Proc. Natl. Acad. Sci. USA"}, {"key": "ref96", "doi-asserted-by": "crossref", "first-page": "309", "DOI": "10.1016/j.ccr.2006.08.021", "article-title": "Regulation of androgen receptor activity by tyrosine phosphorylation", "volume": "10", "author": "Guo", "year": "2006", "journal-title": "Cancer Cell"}, {"key": "ref97", "doi-asserted-by": "crossref", "first-page": "5587", "DOI": "10.1158/0008-5472.CAN-09-4610", "article-title": "Compensatory upregulation of tyrosine kinase etk/bmx in response to androgen deprivation promotes castration-resistant growth of prostate cancer cells", "volume": "70", "author": "Dai", "year": "2010", "journal-title": "Cancer Res"}, {"key": "ref98", "doi-asserted-by": "crossref", "first-page": "5406", "DOI": "10.1093/emboj/19.20.5406", "article-title": "Steroid-induced androgen receptor-oestradiol receptor beta-src complex triggers prostate cancer cell proliferation", "volume": "19", "author": "Migliaccio", "year": "2000", "journal-title": "EMBO J"}, {"key": "ref99", "doi-asserted-by": "crossref", "first-page": "722", "DOI": "10.1210/me.2009-0326", "article-title": "Activation of rac1 is closely related to androgen-independent cell proliferation of prostate cancer cells both in vitro and in vivo", "volume": "24", "author": "Kobayashi", "year": "2010", "journal-title": "Mol. Endocrinol"}, {"key": "ref100", "doi-asserted-by": "crossref", "first-page": "4795", "DOI": "10.1210/endo.142.11.8467", "article-title": "Role of pi3k signaling in survival and progression of lncap prostate cancer cells to the androgen refractory state", "volume": "142", "author": "Murillo", "year": "2001", "journal-title": "Endocrinology"}, {"key": "ref101", "doi-asserted-by": "crossref", "first-page": "631", "DOI": "10.4161/cbt.311", "article-title": "Trail-disc formation is androgen-dependent in the human prostatic carcinoma cell line lncap", "volume": "1", "author": "Rokhlin", "year": "2002", "journal-title": "Cancer Biol. Ther"}, {"key": "ref102", "doi-asserted-by": "crossref", "first-page": "575", "DOI": "10.1016/j.ccr.2011.04.008", "article-title": "Reciprocal feedback regulation of pi3k and androgen receptor signaling in pten-deficient prostate cancer", "volume": "19", "author": "Carver", "year": "2011", "journal-title": "Cancer Cell"}, {"key": "ref103", "doi-asserted-by": "crossref", "first-page": "792", "DOI": "10.1016/j.ccr.2011.05.006", "article-title": "Cell autonomous role of pten in regulating castration-resistant prostate cancer growth", "volume": "19", "author": "Mulholland", "year": "2011", "journal-title": "Cancer Cell"}, {"key": "ref104", "first-page": "6841", "article-title": "Her-2/neu promotes androgen-independent survival and growth of prostate cancer cells through the akt pathway", "volume": "60", "author": "Wen", "year": "2000", "journal-title": "Cancer Res"}, {"key": "ref105", "doi-asserted-by": "crossref", "first-page": "50902", "DOI": "10.1074/jbc.M300676200", "article-title": "Suppression versus induction of androgen receptor functions by the phosphatidylinositol 3-kinase/akt pathway in prostate cancer lncap cells with different passage numbers", "volume": "278", "author": "Lin", "year": "2003", "journal-title": "J. Biol. Chem"}, {"key": "ref106", "doi-asserted-by": "crossref", "first-page": "2172", "DOI": "10.1101/gad.1699608", "article-title": "Aberrant rheb-mediated mtorc1 activation and pten haploinsufficiency are cooperative oncogenic events", "volume": "22", "author": "Nardella", "year": "2008", "journal-title": "Genes. Dev"}, {"key": "ref107", "first-page": "866", "article-title": "Regulation of androgen receptor transactivity and mtor-s6 kinase pathway by rheb in prostate cancer cell proliferation", "volume": "70", "author": "Kobayashi", "year": "2010", "journal-title": "Prostate"}, {"key": "ref108", "first-page": "3051", "article-title": "Targeting akt/mtor and erk mapk signaling inhibits hormone-refractory prostate cancer in a preclinical mouse model", "volume": "118", "author": "Kinkade", "year": "2008", "journal-title": "J. Clin. Invest"}, {"key": "ref109", "doi-asserted-by": "crossref", "first-page": "2547", "DOI": "10.1158/0008-5472.CAN-04-3411", "article-title": "Post-transcriptional regulation of the androgen receptor by mammalian target of rapamycin", "volume": "65", "author": "Cinar", "year": "2005", "journal-title": "Cancer Res"}, {"key": "ref110", "doi-asserted-by": "crossref", "first-page": "e34414", "DOI": "10.1371/journal.pone.0034414", "article-title": "Modulators of prostate cancer cell proliferation and viability identified by short-hairpin rna library screening", "volume": "7", "author": "Dahlman", "year": "2012", "journal-title": "PLoS One"}, {"key": "ref111", "first-page": "6606", "article-title": "Characterization of a novel androgen receptor mutation in a relapsed cwr22 prostate cancer xenograft and cell line", "volume": "62", "author": "Tepper", "year": "2002", "journal-title": "Cancer Res"}, {"key": "ref112", "doi-asserted-by": "crossref", "first-page": "5469", "DOI": "10.1158/0008-5472.CAN-08-0594", "article-title": "Splicing of a novel androgen receptor exon generates a constitutively active androgen receptor that mediates prostate cancer therapy resistance", "volume": "68", "author": "Dehm", "year": "2008", "journal-title": "Cancer Res"}, {"key": "ref113", "doi-asserted-by": "crossref", "first-page": "2305", "DOI": "10.1158/0008-5472.CAN-08-3795", "article-title": "A novel androgen receptor splice variant is up-regulated during prostate cancer progression and promotes androgen depletion-resistant growth", "volume": "69", "author": "Guo", "year": "2009", "journal-title": "Cancer Res"}, {"key": "ref114", "doi-asserted-by": "crossref", "first-page": "16", "DOI": "10.1158/0008-5472.CAN-08-2764", "article-title": "Ligand-independent androgen receptor variants derived from splicing of cryptic exons signify hormone-refractory prostate cancer", "volume": "69", "author": "Hu", "year": "2009", "journal-title": "Cancer Res"}, {"key": "ref115", "doi-asserted-by": "crossref", "first-page": "74", "DOI": "10.1002/humu.21138", "article-title": "Identification of novel truncated androgen receptor (ar) mutants including unreported pre-mrna splicing variants in the 22rv1 hormone-refractory prostate cancer (pca) cell line", "volume": "31", "author": "Marcias", "year": "2010", "journal-title": "Hum. Mutat"}, {"key": "ref116", "doi-asserted-by": "crossref", "first-page": "16759", "DOI": "10.1073/pnas.1012443107", "article-title": "Constitutively active androgen receptor splice variants expressed in castration-resistant prostate cancer require full-length androgen receptor", "volume": "107", "author": "Watson", "year": "2010", "journal-title": "Proc. Natl. Acad. Sci. USA"}, {"key": "ref117", "doi-asserted-by": "crossref", "first-page": "R183", "DOI": "10.1530/ERC-11-0141", "article-title": "Alternatively spliced androgen receptor variants", "volume": "18", "author": "Dehm", "year": "2011", "journal-title": "Endocr. Relat. Cancer"}, {"key": "ref118", "doi-asserted-by": "crossref", "first-page": "1656", "DOI": "10.1002/pros.21382", "article-title": "A snapshot of the expression signature of androgen receptor splicing variants and their distinctive transcriptional activities", "volume": "71", "author": "Hu", "year": "2011", "journal-title": "Prostate"}, {"key": "ref119", "doi-asserted-by": "crossref", "first-page": "e27970", "DOI": "10.1371/journal.pone.0027970", "article-title": "Androgen receptor variants occur frequently in castration resistant prostate cancer metastases", "volume": "6", "author": "Zhang", "year": "2011", "journal-title": "PLoS One"}, {"key": "ref120", "doi-asserted-by": "crossref", "first-page": "1022", "DOI": "10.1111/j.1349-7006.2012.02250.x", "article-title": "Androgen deprivation causes truncation of the c-terminal region of androgen receptor in human prostate cancer lncap cells", "volume": "103", "author": "Harada", "year": "2012", "journal-title": "Cancer Sci"}, {"key": "ref121", "doi-asserted-by": "crossref", "first-page": "2108", "DOI": "10.1158/0008-5472.CAN-10-1998", "article-title": "Intragenic rearrangement and altered rna splicing of the androgen receptor in a cell-based model of prostate cancer progression", "volume": "71", "author": "Li", "year": "2011", "journal-title": "Cancer Res"}, {"key": "ref122", "doi-asserted-by": "crossref", "first-page": "4759", "DOI": "10.1038/onc.2011.637", "article-title": "Ar intragenic deletions linked to androgen receptor splice variant expression and activity in models of prostate cancer progression", "volume": "31", "author": "Li", "year": "2012", "journal-title": "Oncogene"}, {"key": "ref123", "doi-asserted-by": "crossref", "first-page": "5913", "DOI": "10.1158/1078-0432.CCR-11-0728", "article-title": "Resistance to cyp17a1 inhibition with abiraterone in castration-resistant prostate cancer: Induction of steroidogenesis and androgen receptor splice variants", "volume": "17", "author": "Mostaghel", "year": "2011", "journal-title": "Clin. Cancer Res"}, {"key": "ref124", "doi-asserted-by": "crossref", "first-page": "483", "DOI": "10.1158/0008-5472.CAN-12-3630", "article-title": "Androgen receptor splice variants mediate enzalutamide resistance in castration-resistant prostate cancer cell lines", "volume": "73", "author": "Li", "year": "2013", "journal-title": "Cancer Res"}, {"key": "ref125", "doi-asserted-by": "crossref", "first-page": "10765", "DOI": "10.1093/nar/gks888", "article-title": "Persistent androgen receptor-mediated transcription in castration-resistant prostate cancer under androgen-deprived conditions", "volume": "40", "author": "Decker", "year": "2012", "journal-title": "Nucleic Acids Res"}, {"key": "ref126", "doi-asserted-by": "crossref", "first-page": "35", "DOI": "10.1016/j.ccr.2012.11.010", "article-title": "The androgen receptor induces a distinct transcriptional program in castration-resistant prostate cancer in man", "volume": "23", "author": "Sharma", "year": "2013", "journal-title": "Cancer Cell"}, {"key": "ref127", "doi-asserted-by": "crossref", "first-page": "10613", "DOI": "10.1158/0008-5472.CAN-06-0028", "article-title": "Short hairpin rna knockdown of the androgen receptor attenuates ligand-independent activation and delays tumor progression", "volume": "66", "author": "Cheng", "year": "2006", "journal-title": "Cancer Res"}, {"key": "ref128", "doi-asserted-by": "crossref", "first-page": "2309", "DOI": "10.1158/1535-7163.MCT-11-0329", "article-title": "Reduced expression of the androgen receptor by third generation of antisense shows antitumor activity in models of prostate cancer", "volume": "10", "author": "Zhang", "year": "2011", "journal-title": "Mol. Cancer Ther"}, {"key": "ref129", "doi-asserted-by": "crossref", "first-page": "787", "DOI": "10.1126/science.1168175", "article-title": "Development of a second-generation antiandrogen for treatment of advanced prostate cancer", "volume": "324", "author": "Tran", "year": "2009", "journal-title": "Science"}, {"key": "ref130", "doi-asserted-by": "crossref", "first-page": "5379", "DOI": "10.1158/1078-0432.CCR-11-0916", "article-title": "Lupeol, a novel androgen receptor inhibitor: Implications in prostate cancer therapy", "volume": "17", "author": "Siddique", "year": "2011", "journal-title": "Clin. Cancer Res"}, {"key": "ref131", "doi-asserted-by": "crossref", "first-page": "1208", "DOI": "10.1158/0008-5472.CAN_10-3398", "article-title": "Small molecule inhibitors targeting the \u201cachilles\u2019 heel\u201d of androgen receptor activity", "volume": "71", "author": "Sadar", "year": "2011", "journal-title": "Cancer Res"}, {"key": "ref132", "doi-asserted-by": "crossref", "first-page": "535", "DOI": "10.1016/j.ccr.2010.04.027", "article-title": "Regression of castrate-recurrent prostate cancer by a small-molecule inhibitor of the amino-terminus domain of the androgen receptor", "volume": "17", "author": "Andersen", "year": "2010", "journal-title": "Cancer Cell"}, {"key": "ref133", "doi-asserted-by": "crossref", "first-page": "4947", "DOI": "10.1021/ol802021w", "article-title": "Sintokamides a to e, chlorinated peptides from the sponge dysidea sp. That inhibit transactivation of the n-terminus of the androgen receptor in prostate cancer cells", "volume": "10", "author": "Sadar", "year": "2008", "journal-title": "Org. Lett"}, {"key": "ref134", "doi-asserted-by": "crossref", "first-page": "1331", "DOI": "10.1073/pnas.0606718104", "article-title": "Androgen receptor decoy molecules block the growth of prostate cancer", "volume": "104", "author": "Quayle", "year": "2007", "journal-title": "Proc. Natl. Acad. Sci. USA"}, {"key": "ref135", "first-page": "3623", "article-title": "Methylation of the androgen receptor minimal promoter silences transcription in human prostate cancer", "volume": "60", "author": "Kinoshita", "year": "2000", "journal-title": "Cancer Res"}, {"key": "ref136", "doi-asserted-by": "crossref", "first-page": "666", "DOI": "10.1158/1078-0432.CCR-11-1867", "article-title": "Modeling a lethal prostate cancer variant with small-cell carcinoma features", "volume": "18", "author": "Tzelepi", "year": "2012", "journal-title": "Clin. Cancer Res"}], "container-title": ["International Journal of Molecular Sciences"], "language": "en", "link": [{"URL": "http://www.mdpi.com/1422-0067/14/8/15615/pdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 3, 16]], "date-time": "2018-03-16T16:30:14Z", "timestamp": 1521217814000}, "score": 27.087137, "issued": {"date-parts": [[2013, 7, 26]]}, "references-count": 136, "journal-issue": {"published-online": {"date-parts": [[2013, 8]]}, "issue": "8"}, "alternative-id": ["ijms140815615"], "URL": "http://dx.doi.org/10.3390/ijms140815615", "relation": {"cites": []}, "ISSN": ["1422-0067"], "issn-type": [{"value": "1422-0067", "type": "electronic"}], "subject": ["Physical and Theoretical Chemistry", "Inorganic Chemistry", "Organic Chemistry", "Spectroscopy", "Molecular Biology", "Catalysis", "General Medicine", "Computer Science Applications"]}, {"indexed": {"date-parts": [[2019, 12, 4]], "date-time": "2019-12-04T06:21:06Z", "timestamp": 1575440466853}, "reference-count": 23, "publisher": "Wiley", "issue": "9", "license": [{"URL": "http://onlinelibrary.wiley.com/termsAndConditions#vor", "start": {"date-parts": [[2019, 4, 18]], "date-time": "2019-04-18T00:00:00Z", "timestamp": 1555545600000}, "delay-in-days": 0, "content-version": "vor"}, {"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2019, 4, 18]], "date-time": "2019-04-18T00:00:00Z", "timestamp": 1555545600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": ["onlinelibrary.wiley.com"], "crossmark-restriction": true}, "short-container-title": ["Prostate"], "published-print": {"date-parts": [[2019, 6]]}, "DOI": "10.1002/pros.23816", "type": "journal-article", "created": {"date-parts": [[2019, 4, 18]], "date-time": "2019-04-18T17:50:27Z", "timestamp": 1555609827000}, "page": "1043-1052", "update-policy": "http://dx.doi.org/10.1002/crossmark_policy", "source": "Crossref", "is-referenced-by-count": 1, "title": ["Differential expression of androgen receptor variants in hormone\u2010sensitive prostate cancer xenografts, castration\u2010resistant sublines, and patient specimens according to the treatment sequence"], "prefix": "10.1002", "volume": "79", "author": [{"ORCID": "http://orcid.org/0000-0001-5744-2051", "authenticated-orcid": false, "given": "Mariko", "family": "Honda", "sequence": "first", "affiliation": [{"name": "Department of UrologyThe Jikei University School of MedicineTokyo Japan"}]}, {"ORCID": "http://orcid.org/0000-0002-5673-1553", "authenticated-orcid": false, "given": "Takahiro", "family": "Kimura", "sequence": "additional", "affiliation": [{"name": "Department of UrologyThe Jikei University School of MedicineTokyo Japan"}]}, {"given": "Yuko", "family": "Kamata", "sequence": "additional", "affiliation": [{"name": "Division of OncologyResearch Center for Medical SciencesThe Jikei University School of MedicineTokyo Japan"}]}, {"given": "Kojiro", "family": "Tashiro", "sequence": "additional", "affiliation": [{"name": "Department of UrologyThe Jikei University School of MedicineTokyo Japan"}]}, {"given": "Shoji", "family": "Kimura", "sequence": "additional", "affiliation": [{"name": "Department of UrologyThe Jikei University School of MedicineTokyo Japan"}]}, {"given": "Yusuke", "family": "Koike", "sequence": "additional", "affiliation": [{"name": "Department of UrologyThe Jikei University School of MedicineTokyo Japan"}]}, {"given": "Shun", "family": "Sato", "sequence": "additional", "affiliation": [{"name": "Department of PathologyThe Jikei University School of MedicineTokyo Japan"}]}, {"given": "Takashi", "family": "Yorozu", "sequence": "additional", "affiliation": [{"name": "Department of PathologyThe Jikei University School of MedicineTokyo Japan"}]}, {"given": "Bungo", "family": "Furusato", "sequence": "additional", "affiliation": [{"name": "Department of PathologyNagasaki University Graduate School of Biomedical SciencesNagasaki Japan"}]}, {"given": "Hiroyuki", "family": "Takahashi", "sequence": "additional", "affiliation": [{"name": "Department of PathologyThe Jikei University School of MedicineTokyo Japan"}]}, {"given": "Hiroshi", "family": "Kiyota", "sequence": "additional", "affiliation": [{"name": "Department of UrologyThe Jikei University School of MedicineTokyo Japan"}]}, {"given": "Shin", "family": "Egawa", "sequence": "additional", "affiliation": [{"name": "Department of UrologyThe Jikei University School of MedicineTokyo Japan"}]}], "member": "311", "published-online": {"date-parts": [[2019, 4, 18]]}, "reference": [{"key": "e_1_2_8_1_2_1", "DOI": "10.3322/caac.21332", "doi-asserted-by": "publisher"}, {"key": "e_1_2_8_1_3_1", "DOI": "10.1016/S0140-6736(14)61947-4", "doi-asserted-by": "publisher"}, {"key": "e_1_2_8_1_4_1", "DOI": "10.1038/nrurol.2014.42", "doi-asserted-by": "publisher"}, {"key": "e_1_2_8_1_5_1", "DOI": "10.3389/fphar.2017.00836", "doi-asserted-by": "publisher"}, {"key": "e_1_2_8_1_6_1", "DOI": "10.1158/0008-5472.CAN-08-3795", "doi-asserted-by": "publisher"}, {"key": "e_1_2_8_1_7_1", "DOI": "10.1172/JCI41824", "doi-asserted-by": "publisher"}, {"key": "e_1_2_8_1_8_1", "DOI": "10.1056/NEJMoa1315815", "doi-asserted-by": "publisher"}, {"key": "e_1_2_8_1_9_1", "DOI": "10.1016/j.cell.2015.05.001", "doi-asserted-by": "publisher"}, {"key": "e_1_2_8_1_10_1", "DOI": "10.1016/j.juro.2016.06.095", "doi-asserted-by": "publisher"}, {"key": "e_1_2_8_1_11_1", "DOI": "10.1002/pros.21016", "doi-asserted-by": "publisher"}, {"key": "e_1_2_8_1_12_1", "DOI": "10.1002/pros.23238", "doi-asserted-by": "publisher"}, {"key": "e_1_2_8_1_13_1", "DOI": "10.1530/jrf.0.0780219", "doi-asserted-by": "publisher"}, {"key": "e_1_2_8_1_14_1", "DOI": "10.1007/s00018-011-0766-7", "doi-asserted-by": "publisher"}, {"key": "e_1_2_8_1_15_1", "DOI": "10.1038/ncomms13668", "doi-asserted-by": "publisher"}, {"key": "e_1_2_8_1_16_1", "DOI": "10.18632/oncotarget.4396", "doi-asserted-by": "publisher"}, {"key": "e_1_2_8_1_17_1", "DOI": "10.18632/oncotarget.1802", "doi-asserted-by": "publisher"}, {"key": "e_1_2_8_1_18_1", "DOI": "10.1016/j.eururo.2014.05.005", "doi-asserted-by": "publisher"}, {"key": "e_1_2_8_1_19_1", "DOI": "10.1172/JCI122819", "doi-asserted-by": "publisher"}, {"key": "e_1_2_8_1_20_1", "DOI": "10.1016/j.eururo.2016.03.049", "doi-asserted-by": "publisher"}, {"key": "e_1_2_8_1_21_1", "DOI": "10.1038/onc.2011.637", "doi-asserted-by": "publisher"}, {"key": "e_1_2_8_1_22_1", "DOI": "10.1158/1078-0432.CCR-17-2006", "doi-asserted-by": "publisher"}, {"key": "e_1_2_8_1_23_1", "DOI": "10.1210/en.2017-00086", "doi-asserted-by": "publisher"}, {"key": "e_1_2_8_1_24_1", "DOI": "10.1158/0008-5472.CAN-11-3892", "doi-asserted-by": "publisher"}], "container-title": ["The Prostate"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fpros.23816", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://onlinelibrary.wiley.com/doi/pdf/10.1002/pros.23816", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://onlinelibrary.wiley.com/doi/full-xml/10.1002/pros.23816", "content-type": "application/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://onlinelibrary.wiley.com/doi/pdf/10.1002/pros.23816", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 15]], "date-time": "2019-05-15T07:32:54Z", "timestamp": 1557905574000}, "score": 26.980312, "issued": {"date-parts": [[2019, 4, 18]]}, "references-count": 23, "journal-issue": {"published-online": {"date-parts": [[2019, 4, 23]]}, "published-print": {"date-parts": [[2019, 6]]}, "issue": "9"}, "alternative-id": ["10.1002/pros.23816"], "URL": "http://dx.doi.org/10.1002/pros.23816", "archive": ["Portico"], "relation": {"cites": []}, "ISSN": ["0270-4137", "1097-0045"], "issn-type": [{"value": "0270-4137", "type": "print"}, {"value": "1097-0045", "type": "electronic"}], "subject": ["Urology", "Oncology"]}, {"indexed": {"date-parts": [[2019, 12, 20]], "date-time": "2019-12-20T00:04:01Z", "timestamp": 1576800241852}, "reference-count": 0, "publisher": "American Society of Clinical Oncology (ASCO)", "issue": "4_suppl", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["JCO"], "published-print": {"date-parts": [[2014, 2, 1]]}, "abstract": "<jats:p> 207 </jats:p><jats:p> Background: Zoledronic acid (ZA) reduces the onset risk of skeletal-related events (SRE) caused by bone metastasis in prostate cancer (PCa) patients and improves the QOL. Therefore ZA has become a standard supportive therapy for PCa with bone metastasis. However, it remains unclear when the physicians should start ZA treatment. In the present study, we investigated whether combination of ZA could delay PSA relapse of PCa and prevent SREs. Methods: The patients were randomly classified in two groups (combined androgen blockade (CAB) alone group and CAB + ZA treatment group). In the CAB + ZA group, 4 mg ZA was intravenously administered every 4 weeks with the start of treatment. The first end point was a period to PSA relapse, and the secondary end point was SREs rate. Results: Untreated 60 PCa patients with bone metastasis were enrolled by 2011 from 2006. Thirty one patients were treated with CAB alone and 29 patients were treated with CAB + ZA. There were no significant differences in the baseline characteristics in the both groups, and the mean observation period was 27.4 months and 32.1 months, respectively. Although there was no significant difference in progression free survival (PFS) (p=0.073), tendency that CAB + ZA shows better PFS than CAB alone group was observed (time to 50% PFS was extended 11.6 months than CAB alone group). Moreover, the sub analysis using the patients with more than Gleason score 7, CAB +ZA group showed significantly longer PFS than the CAB group (p=0.021). And statistically significant difference was recognized in SRE rate between the two groups (p=0.019), ZA tended to delay the occurrence of SRE in PCa patients. Conclusions: This result indicates that the use of ZA at the beginning of hormonal therapy have not only a preventive effect on the occurrence of SREs but also a relapse-delaying effect, especially in the patients with high Gleason score and severe bone metastasis. Though careful observation is essential, since the long-term use of ZA may increase the incidence of adverse effects, CAB-ZA treatment may be recommended for the treatment of PCa patients with bone metastasis. </jats:p>", "DOI": "10.1200/jco.2014.32.4_suppl.207", "type": "journal-article", "created": {"date-parts": [[2017, 2, 24]], "date-time": "2017-02-24T11:31:41Z", "timestamp": 1487935901000}, "page": "207-207", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Efficacy of combined androgen blockade with zoledronic acid treatment in prostate cancer with bone metastasis: The Zoledronic Acid/Androgen Blockade Trial on Prostate Cancer (Zabton-PC) study."], "prefix": "10.1200", "volume": "32", "author": [{"given": "Satoru", "family": "Ueno", "sequence": "first", "affiliation": [{"name": "Kanazawa University Graduate School of Medical Science, Kanazawa, Japan"}]}, {"given": "Atsushi", "family": "Mizokami", "sequence": "additional", "affiliation": [{"name": "Kanazawa University Graduate School of Medical Science, Kanazawa, Japan"}]}, {"given": "Takashi", "family": "Fukagai", "sequence": "additional", "affiliation": [{"name": "Showa University School of Medicine, Tokyo, Japan"}]}, {"given": "Naohiro", "family": "Fujimoto", "sequence": "additional", "affiliation": [{"name": "University of Occupational and Environmental Health, Kitakyusyu, Japan"}]}, {"given": "Hitoshi", "family": "Ohoka", "sequence": "additional", "affiliation": [{"name": "National Hospital Organization, Kobe Medical Center, Kobe, Japan"}]}, {"given": "Yukihiro", "family": "Kondo", "sequence": "additional", "affiliation": [{"name": "Department of Urology, Nippon Medical School, Tokyo, Japan"}]}, {"given": "Gaku", "family": "Arai", "sequence": "additional", "affiliation": [{"name": "Dokkyo Medical University Koshigaya Hospital, Saitama, Japan"}]}, {"given": "Hisamitsu", "family": "Ide", "sequence": "additional", "affiliation": [{"name": "Teikyo University Hospital, Tokyo, Japan"}]}, {"given": "Mikio", "family": "Namiki", "sequence": "additional", "affiliation": [{"name": "Kanazawa University Graduate School of Medical Science, Kanazawa, Japan"}]}], "member": "233", "container-title": ["Journal of Clinical Oncology"], "language": "en", "link": [{"URL": "http://ascopubs.org/doi/pdfdirect/10.1200/jco.2014.32.4_suppl.207", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T21:59:41Z", "timestamp": 1574891981000}, "score": 26.807026, "issued": {"date-parts": [[2014, 2, 1]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2014, 2, 1]]}, "issue": "4_suppl"}, "alternative-id": ["10.1200/jco.2014.32.4_suppl.207"], "URL": "http://dx.doi.org/10.1200/jco.2014.32.4_suppl.207", "ISSN": ["0732-183X", "1527-7755"], "issn-type": [{"value": "0732-183X", "type": "print"}, {"value": "1527-7755", "type": "electronic"}], "subject": ["Cancer Research", "Oncology"]}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T19:26:59Z", "timestamp": 1574364419048}, "reference-count": 13, "publisher": "Elsevier BV", "issue": "1-2", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2008, 7, 1]], "date-time": "2008-07-01T00:00:00Z", "timestamp": 1214870400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Mathematical Biosciences"], "published-print": {"date-parts": [[2008, 7]]}, "DOI": "10.1016/j.mbs.2008.03.001", "type": "journal-article", "created": {"date-parts": [[2008, 4, 17]], "date-time": "2008-04-17T13:33:01Z", "timestamp": 1208439181000}, "page": "134-139", "source": "Crossref", "is-referenced-by-count": 31, "title": ["A nonlinear model with competition between prostate tumor cells and its application to intermittent androgen suppression therapy of prostate cancer"], "prefix": "10.1016", "volume": "214", "author": [{"given": "Takashi", "family": "Shimada", "sequence": "first", "affiliation": []}, {"given": "Kazuyuki", "family": "Aihara", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Mathematical Biosciences"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0025556408000412?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0025556408000412?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 12, 30]], "date-time": "2018-12-30T01:56:08Z", "timestamp": 1546134968000}, "score": 26.713215, "issued": {"date-parts": [[2008, 7]]}, "references-count": 13, "journal-issue": {"published-print": {"date-parts": [[2008, 7]]}, "issue": "1-2"}, "alternative-id": ["S0025556408000412"], "URL": "http://dx.doi.org/10.1016/j.mbs.2008.03.001", "ISSN": ["0025-5564"], "issn-type": [{"value": "0025-5564", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 24]], "date-time": "2019-11-24T10:39:58Z", "timestamp": 1574591998399}, "reference-count": 0, "publisher": "Ovid Technologies (Wolters Kluwer Health)", "issue": "4S", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2015, 4, 1]], "date-time": "2015-04-01T00:00:00Z", "timestamp": 1427846400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Journal of Urology"], "published-print": {"date-parts": [[2015, 4]]}, "DOI": "10.1016/j.juro.2015.02.2683", "type": "journal-article", "created": {"date-parts": [[2015, 3, 31]], "date-time": "2015-03-31T05:20:54Z", "timestamp": 1427779254000}, "source": "Crossref", "is-referenced-by-count": 0, "title": ["MP73-07 BONE MANAGEMENT OF PROSTATE CANCER: FRAX TOOL COMBINATION WITH BMD CAN REDUCE UNNECESSARY TREATMENT"], "prefix": "10.1097", "volume": "193", "author": [{"given": "Shusei", "family": "Fusayasu", "sequence": "first", "affiliation": [{"name": "Yokohama, Japan"}]}, {"given": "Takashi", "family": "Kawahara", "sequence": "additional", "affiliation": [{"name": "Yokohama, Japan"}]}, {"given": "Hiroshi", "family": "Miyamoto", "sequence": "additional", "affiliation": [{"name": "Baltimore, MD"}]}, {"given": "Masahiro", "family": "Yao", "sequence": "additional", "affiliation": [{"name": "Yokohama, Japan"}]}, {"given": "Hiroji", "family": "Uemura", "sequence": "additional", "affiliation": [{"name": "Yokohama, Japan"}]}], "member": "276", "container-title": ["Journal of Urology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0022534715029948?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0022534715029948?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 6, 17]], "date-time": "2019-06-17T16:21:38Z", "timestamp": 1560788498000}, "score": 26.467808, "issued": {"date-parts": [[2015, 4]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2015, 4]]}, "issue": "4S"}, "alternative-id": ["10.1016/j.juro.2015.02.2683"], "URL": "http://dx.doi.org/10.1016/j.juro.2015.02.2683", "ISSN": ["0022-5347", "1527-3792"], "issn-type": [{"value": "0022-5347", "type": "print"}, {"value": "1527-3792", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 25]], "date-time": "2019-11-25T19:48:53Z", "timestamp": 1574711333484}, "reference-count": 36, "publisher": "Wiley", "issue": "3", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1", "start": {"date-parts": [[2016, 10, 24]], "date-time": "2016-10-24T00:00:00Z", "timestamp": 1477267200000}, "delay-in-days": 0, "content-version": "tdm"}, {"URL": "http://onlinelibrary.wiley.com/termsAndConditions", "start": {"date-parts": [[2016, 10, 24]], "date-time": "2016-10-24T00:00:00Z", "timestamp": 1477267200000}, "delay-in-days": 0, "content-version": "vor"}], "funder": [{"DOI": "10.13039/501100004376", "name": "Terry Fox Research Institute", "doi-asserted-by": "publisher", "award": ["1062"]}, {"name": "JSPS KAKENHI", "award": ["16K20144"]}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Prostate"], "published-print": {"date-parts": [[2017, 2]]}, "DOI": "10.1002/pros.23269", "type": "journal-article", "created": {"date-parts": [[2016, 10, 24]], "date-time": "2016-10-24T10:57:03Z", "timestamp": 1477306623000}, "page": "309-320", "source": "Crossref", "is-referenced-by-count": 1, "title": ["Suppression of LIM and SH3 Domain Protein 1 (LASP1) Negatively Regulated by Androgen Receptor Delays Castration Resistant Prostate Cancer Progression"], "prefix": "10.1002", "volume": "77", "author": [{"given": "Takashi", "family": "Dejima", "sequence": "first", "affiliation": [{"name": "Vancouver Prostate Centre and Department of Urologic Sciences; University of British Columbia; Vancouver British Columbia Canada"}, {"name": "Department of Urology; Graduate School of Medical Sciences; Kyushu University; Fukuoka Japan"}]}, {"given": "Kenjiro", "family": "Imada", "sequence": "additional", "affiliation": [{"name": "Vancouver Prostate Centre and Department of Urologic Sciences; University of British Columbia; Vancouver British Columbia Canada"}]}, {"given": "Ario", "family": "Takeuchi", "sequence": "additional", "affiliation": [{"name": "Department of Urology; Graduate School of Medical Sciences; Kyushu University; Fukuoka Japan"}]}, {"given": "Masaki", "family": "Shiota", "sequence": "additional", "affiliation": [{"name": "Department of Urology; Graduate School of Medical Sciences; Kyushu University; Fukuoka Japan"}]}, {"given": "Jeffrey", "family": "Leong", "sequence": "additional", "affiliation": [{"name": "Vancouver Prostate Centre and Department of Urologic Sciences; University of British Columbia; Vancouver British Columbia Canada"}]}, {"given": "Tabitha", "family": "Tombe", "sequence": "additional", "affiliation": [{"name": "Vancouver Prostate Centre and Department of Urologic Sciences; University of British Columbia; Vancouver British Columbia Canada"}]}, {"given": "Kevin", "family": "Tam", "sequence": "additional", "affiliation": [{"name": "Vancouver Prostate Centre and Department of Urologic Sciences; University of British Columbia; Vancouver British Columbia Canada"}]}, {"given": "Ladan", "family": "Fazli", "sequence": "additional", "affiliation": [{"name": "Vancouver Prostate Centre and Department of Urologic Sciences; University of British Columbia; Vancouver British Columbia Canada"}]}, {"given": "Seiji", "family": "Naito", "sequence": "additional", "affiliation": [{"name": "Department of Urology; Graduate School of Medical Sciences; Kyushu University; Fukuoka Japan"}]}, {"given": "Martin E.", "family": "Gleave", "sequence": "additional", "affiliation": [{"name": "Vancouver Prostate Centre and Department of Urologic Sciences; University of British Columbia; Vancouver British Columbia Canada"}]}, {"given": "Christopher J.", "family": "Ong", "sequence": "additional", "affiliation": [{"name": "Vancouver Prostate Centre and Department of Urologic Sciences; University of British Columbia; Vancouver British Columbia Canada"}, {"name": "Department of Surgery; University of British Columbia; Vancouver British Columbia Canada"}]}], "member": "311", "published-online": {"date-parts": [[2016, 10, 24]]}, "reference": [{"issue": "3", "key": "10.1002/pros.23269-BIB0001|pros23269-cit-0001", "doi-asserted-by": "crossref", "first-page": "251", "DOI": "10.1097/CCO.0b013e32835105b3", "article-title": "The androgen/androgen receptor axis in prostate cancer", "volume": "24", "author": "Bluemn", "year": "2012", "journal-title": "Curr Opin Oncol"}, {"issue": "18", "key": "10.1002/pros.23269-BIB0002|pros23269-cit-0002", "doi-asserted-by": "crossref", "first-page": "5913", "DOI": "10.1158/1078-0432.CCR-11-0728", "article-title": "Resistance to CYP17A1 inhibition with abiraterone in castration-resistant prostate cancer: Induction of steroidogenesis and androgen receptor splice variants", "volume": "17", "author": "Mostaghel", "year": "2011", "journal-title": "Clin Cancer Res"}, {"issue": "2", "key": "10.1002/pros.23269-BIB0003|pros23269-cit-0003", "doi-asserted-by": "crossref", "first-page": "483", "DOI": "10.1158/0008-5472.CAN-12-3630", "article-title": "Androgen receptor splice variants mediate enzalutamide resistance in castration-resistant prostate cancer cell lines", "volume": "73", "author": "Li", "year": "2013", "journal-title": "Cancer Res"}, {"issue": "9724", "key": "10.1002/pros.23269-BIB0004|pros23269-cit-0004", "doi-asserted-by": "crossref", "first-page": "1437", "DOI": "10.1016/S0140-6736(10)60172-9", "article-title": "Prostate cancer foundation/department of defense prostate cancer clinical trials C. Antitumour activity of MDV3100 in castration-resistant prostate cancer: A phase1-2 study", "volume": "375", "author": "Scher", "year": "2010", "journal-title": "Lancet"}, {"issue": "2", "key": "10.1002/pros.23269-BIB0005|pros23269-cit-0005", "doi-asserted-by": "crossref", "first-page": "122", "DOI": "10.1038/pcan.2014.53", "article-title": "Activity of enzalutamide in men with metastatic castration-resistant prostate cancer is affected by prior treatment with abiraterone and/or docetaxel", "volume": "18", "author": "Cheng", "year": "2015", "journal-title": "Prostate Cancer Prostatic Dis"}, {"issue": "3", "key": "10.1002/pros.23269-BIB0006|pros23269-cit-0006", "doi-asserted-by": "crossref", "first-page": "245", "DOI": "10.1016/0014-5793(95)01040-L", "article-title": "Lasp-1 (MLN 50) defines a new LIM protein subfamily characterized by the association of LIM and SH3 domains", "volume": "373", "author": "Tomasetto", "year": "1995", "journal-title": "FEBS Lett"}, {"issue": "1", "key": "10.1002/pros.23269-BIB0007|pros23269-cit-0007", "doi-asserted-by": "crossref", "first-page": "308", "DOI": "10.1016/j.bbrc.2004.08.235", "article-title": "Phosphorylation of mouse LASP-1 on threonine 156 by cAMP- and cGMP-dependent protein kinase", "volume": "324", "author": "Keicher", "year": "2004", "journal-title": "Biochem Biophys Res Commun"}, {"issue": "Pt 6", "key": "10.1002/pros.23269-BIB0008|pros23269-cit-0008", "doi-asserted-by": "crossref", "first-page": "995", "DOI": "10.1242/jcs.02825", "article-title": "Identification of palladin isoforms and characterization of an isoform-specific interaction between Lasp-1 and palladin", "volume": "119", "author": "Rachlin", "year": "2006", "journal-title": "J Cell Sci"}, {"issue": "2", "key": "10.1002/pros.23269-BIB0009|pros23269-cit-0009", "doi-asserted-by": "crossref", "first-page": "296", "DOI": "10.1038/sj.bjc.6603545", "article-title": "Overexpression of LASP-1 mediates migration and proliferation of human ovarian cancer cells and influences zyxin localisation", "volume": "96", "author": "Grunewald", "year": "2007", "journal-title": "Br J Cancer"}, {"issue": "9", "key": "10.1002/pros.23269-BIB0010|pros23269-cit-0010", "doi-asserted-by": "crossref", "first-page": "1226", "DOI": "10.1136/gut.2009.202739", "article-title": "Promotion of colorectal cancer growth and metastasis by the LIM and SH3 domain protein 1", "volume": "59", "author": "Zhao", "year": "2010", "journal-title": "Gut"}, {"issue": "3", "key": "10.1002/pros.23269-BIB0011|pros23269-cit-0011", "doi-asserted-by": "crossref", "first-page": "528", "DOI": "10.1016/j.jhep.2008.10.025", "article-title": "LIM and SH3 protein 1 (Lasp1) is a novel p53 transcriptional target involved in hepatocellular carcinoma", "volume": "50", "author": "Wang", "year": "2009", "journal-title": "J Hepatol"}, {"issue": "12", "key": "10.1002/pros.23269-BIB0012|pros23269-cit-0012", "doi-asserted-by": "crossref", "first-page": "2918", "DOI": "10.18632/oncotarget.1928", "article-title": "Loss of tumor suppressor mir-203 mediates overexpression of LIM and SH3 Protein 1 (LASP1) in high-risk prostate cancer thereby increasing cell proliferation and migration", "volume": "5", "author": "Hailer", "year": "2014", "journal-title": "Oncotarget"}, {"issue": "4", "key": "10.1002/pros.23269-BIB0013|pros23269-cit-0013", "doi-asserted-by": "crossref", "first-page": "e10050", "DOI": "10.1371/journal.pone.0010050", "article-title": "LIM SH3 protein-1 modulates CXCR2-mediated cell migration", "volume": "5", "author": "Raman", "year": "2010", "journal-title": "PLoS ONE"}, {"issue": "4", "key": "10.1002/pros.23269-BIB0014|pros23269-cit-0014", "doi-asserted-by": "crossref", "first-page": "e35340", "DOI": "10.1371/journal.pone.0035340", "article-title": "Lasp-1 regulates podosome function", "volume": "7", "author": "Stolting", "year": "2012", "journal-title": "PLoS ONE"}, {"issue": "22", "key": "10.1002/pros.23269-BIB0015|pros23269-cit-0015", "doi-asserted-by": "crossref", "first-page": "5835", "DOI": "10.1158/1078-0432.CCR-14-0485", "article-title": "LIM and SH3 protein 1 induces TGFbeta-mediated epithelial-mesenchymal transition in human colorectal cancer by regulating S100A4 expression", "volume": "20", "author": "Wang", "year": "2014", "journal-title": "Clin Cancer Res"}, {"issue": "5", "key": "10.1002/pros.23269-BIB0016|pros23269-cit-0016", "doi-asserted-by": "crossref", "first-page": "567", "DOI": "10.1158/1535-7163.MCT-12-0798", "article-title": "A novel antiandrogen, compound 30, suppresses castration-resistant and MDV3100-resistant prostate cancer growth in vitro and in vivo", "volume": "12", "author": "Kuruma", "year": "2013", "journal-title": "Mol Cancer Ther"}, {"issue": "16", "key": "10.1002/pros.23269-BIB0017|pros23269-cit-0017", "doi-asserted-by": "crossref", "first-page": "5206", "DOI": "10.1158/0008-5472.CAN-13-0359", "article-title": "Cotargeting androgen receptor and clusterin delays castrate-resistant prostate cancer progression by inhibiting adaptive stress response and AR stability", "volume": "73", "author": "Matsumoto", "year": "2013", "journal-title": "Cancer Res"}, {"issue": "21", "key": "10.1002/pros.23269-BIB0018|pros23269-cit-0018", "doi-asserted-by": "crossref", "first-page": "4845", "DOI": "10.1158/1078-0432.CCR-15-0866", "article-title": "Generation 2.5 antisense oligonucleotides targeting the androgen receptor and its splice variants suppress enzalutamide resistant prostate cancer cell growth", "volume": "1", "author": "Yamamoto", "year": "2015", "journal-title": "Clin Cancer Res"}, {"issue": "2", "key": "10.1002/pros.23269-BIB0019|pros23269-cit-0019", "doi-asserted-by": "crossref", "first-page": "156", "DOI": "10.1002/1097-0045(20000701)44:2<156::AID-PROS8>3.0.CO;2-8", "article-title": "Polymeric micellar paclitaxel phosphorylates Bcl-2 and induces apoptotic regression of androgen-independent LNCaP prostate tumors", "volume": "44", "author": "Leung", "year": "2000", "journal-title": "Prostate"}, {"issue": "17", "key": "10.1002/pros.23269-BIB0020|pros23269-cit-0020", "doi-asserted-by": "crossref", "first-page": "5838", "DOI": "10.1158/0008-5472.CAN-11-0994", "article-title": "Clusterin inhibition using OGX-011 synergistically enhances Hsp90 inhibitor activity by suppressing the heat shock response in castrate-resistant prostate cancer", "volume": "71", "author": "Lamoureux", "year": "2011", "journal-title": "Cancer Res"}, {"issue": "6", "key": "10.1002/pros.23269-BIB0021|pros23269-cit-0021", "doi-asserted-by": "crossref", "first-page": "e66855", "DOI": "10.1371/journal.pone.0066855", "article-title": "Discovery and validation of a prostate cancer genomic classifier that predicts early metastasis following radical prostatectomy", "volume": "8", "author": "Erho", "year": "2013", "journal-title": "PLoS ONE"}, {"issue": "40", "key": "10.1002/pros.23269-BIB0022|pros23269-cit-0022", "doi-asserted-by": "crossref", "first-page": "6185", "DOI": "10.1038/sj.onc.1208772", "article-title": "Gene expression profiles in cells transformed by overexpression of the IGF-I receptor", "volume": "24", "author": "Loughran", "year": "2005", "journal-title": "Oncogene"}, {"issue": "10", "key": "10.1002/pros.23269-BIB0023|pros23269-cit-0023", "doi-asserted-by": "crossref", "first-page": "1372", "DOI": "10.1038/labinvest.3700158", "article-title": "Tumor-associated E-cadherin mutations do not induce Wnt target gene expression, but affect E-cadherin repressors", "volume": "84", "author": "Laux", "year": "2004", "journal-title": "Lab Invest"}, {"issue": "5", "key": "10.1002/pros.23269-BIB0024|pros23269-cit-0024", "doi-asserted-by": "crossref", "first-page": "1054", "DOI": "10.1093/carcin/bgi324", "article-title": "Prostatic intraepithelial neoplasia and adenocarcinoma in mice expressing a probasin-Neu oncogenic transgene", "volume": "27", "author": "Li", "year": "2006", "journal-title": "Carcinogenesis"}, {"issue": "1", "key": "10.1002/pros.23269-BIB0025|pros23269-cit-0025", "doi-asserted-by": "crossref", "first-page": "39", "DOI": "10.1158/1078-0432.CCR-08-1726", "article-title": "In vivo knockdown of the androgen receptor results in growth inhibition and regression of well-established, castration-resistant prostate tumors", "volume": "15", "author": "Snoek", "year": "2009", "journal-title": "Clin Cancer Res"}, {"issue": "2", "key": "10.1002/pros.23269-BIB0026|pros23269-cit-0026", "doi-asserted-by": "crossref", "first-page": "245", "DOI": "10.1016/j.cell.2009.04.056", "article-title": "Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer", "volume": "138", "author": "Wang", "year": "2009", "journal-title": "Cell"}, {"issue": "11", "key": "10.1002/pros.23269-BIB0027|pros23269-cit-0027", "doi-asserted-by": "crossref", "first-page": "1645", "DOI": "10.1038/sj.bjc.6605685", "article-title": "Nuclear localisation of LASP-1 correlates with poor long-term survival in female breast cancer", "volume": "102", "author": "Frietsch", "year": "2010", "journal-title": "Br J Cancer"}, {"key": "10.1002/pros.23269-BIB0028|pros23269-cit-0028", "doi-asserted-by": "crossref", "first-page": "198", "DOI": "10.1186/1471-2407-7-198", "article-title": "Nuclear localization and cytosolic overexpression of LASP-1 correlates with tumor size and nodal-positivity of human breast carcinoma", "volume": "7", "author": "Grunewald", "year": "2007", "journal-title": "BMC Cancer"}, {"issue": "4", "key": "10.1002/pros.23269-BIB0029|pros23269-cit-0029", "doi-asserted-by": "crossref", "first-page": "E27", "DOI": "10.1002/ijc.29147", "article-title": "The expression of glucocorticoid receptor is negatively regulated by active androgen receptor signaling in prostate tumors", "volume": "136", "author": "Xie", "year": "2015", "journal-title": "Int J Cancer"}, {"issue": "3", "key": "10.1002/pros.23269-BIB0030|pros23269-cit-0030", "first-page": "365", "article-title": "Mechanisms of resistance in castration-resistant prostate cancer (CRPC)", "volume": "4", "author": "Chandrasekar", "year": "2015", "journal-title": "Transl Androl Urol"}, {"issue": "3", "key": "10.1002/pros.23269-BIB0031|pros23269-cit-0031", "doi-asserted-by": "crossref", "first-page": "280", "DOI": "10.1038/6495", "article-title": "A mechanism for hormone-independent prostate cancer through modulation of androgen receptor signaling by the HER-2/neu tyrosine kinase", "volume": "5", "author": "Craft", "year": "1999", "journal-title": "Nat Med"}, {"issue": "20", "key": "10.1002/pros.23269-BIB0032|pros23269-cit-0032", "first-page": "5474", "article-title": "Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor, and epidermal growth factor", "volume": "54", "author": "Culig", "year": "1994", "journal-title": "Cancer Res"}, {"issue": "12", "key": "10.1002/pros.23269-BIB0033|pros23269-cit-0033", "doi-asserted-by": "crossref", "first-page": "1152", "DOI": "10.1593/neo.07769", "article-title": "Expression of androgen receptor is negatively regulated by p53", "volume": "9", "author": "Alimirah", "year": "2007", "journal-title": "Neoplasia"}, {"key": "10.1002/pros.23269-BIB0034|pros23269-cit-0034", "doi-asserted-by": "crossref", "first-page": "163", "DOI": "10.1186/1743-422X-9-163", "article-title": "Role of hepatitis B virus X protein in regulating LIM and SH3 protein 1 (LASP-1) expression to mediate proliferation and migration of hepatoma cells", "volume": "9", "author": "Tang", "year": "2012", "journal-title": "Virol J"}, {"issue": "2", "key": "10.1002/pros.23269-BIB0035|pros23269-cit-0035", "doi-asserted-by": "crossref", "first-page": "253", "DOI": "10.4161/cc.8.2.7550", "article-title": "P21Cip1/WAF1 mediates cyclin B1 degradation in response to DNA damage", "volume": "8", "author": "Gillis", "year": "2009", "journal-title": "Cell Cycle"}, {"issue": "6", "key": "10.1002/pros.23269-BIB0036|pros23269-cit-0036", "doi-asserted-by": "crossref", "first-page": "468", "DOI": "10.1038/nrc1631", "article-title": "Antisense therapy for cancer", "volume": "5", "author": "Gleave", "year": "2005", "journal-title": "Nat Rev Cancer"}], "container-title": ["The Prostate"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fpros.23269", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fpros.23269", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://onlinelibrary.wiley.com/wol1/doi/10.1002/pros.23269/fullpdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 6, 25]], "date-time": "2017-06-25T01:56:17Z", "timestamp": 1498355777000}, "score": 26.375189, "subtitle": ["LASP1 Targeting Therapy in Prostate Cancer"], "issued": {"date-parts": [[2016, 10, 24]]}, "references-count": 36, "journal-issue": {"published-print": {"date-parts": [[2017, 2]]}, "issue": "3"}, "URL": "http://dx.doi.org/10.1002/pros.23269", "archive": ["Portico"], "relation": {"cites": []}, "ISSN": ["0270-4137"], "issn-type": [{"value": "0270-4137", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 24]], "date-time": "2019-11-24T10:40:07Z", "timestamp": 1574592007267}, "reference-count": 0, "publisher": "Ovid Technologies (Wolters Kluwer Health)", "issue": "4S", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2015, 4, 1]], "date-time": "2015-04-01T00:00:00Z", "timestamp": 1427846400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Journal of Urology"], "published-print": {"date-parts": [[2015, 4]]}, "DOI": "10.1016/j.juro.2015.02.2811", "type": "journal-article", "created": {"date-parts": [[2015, 3, 31]], "date-time": "2015-03-31T05:32:49Z", "timestamp": 1427779969000}, "source": "Crossref", "is-referenced-by-count": 0, "title": ["MP49-16 ENZALUTAMIDE INHIBITS ANDROGEN RECEPTOR-POSITIVE BLADDER CANCER CELL GROWTH"], "prefix": "10.1097", "volume": "193", "author": [{"given": "Takashi", "family": "Kawahara", "sequence": "first", "affiliation": [{"name": "Baltimore, MD"}]}, {"given": "Hiroki", "family": "Ide", "sequence": "additional", "affiliation": [{"name": "Baltimore, MD"}]}, {"given": "Eiji", "family": "Kashiwagi", "sequence": "additional", "affiliation": [{"name": "Baltimore, MD"}]}, {"given": "Leonardo", "family": "Reis", "sequence": "additional", "affiliation": [{"name": "Baltimore, MD"}]}, {"given": "Yichun", "family": "Zheng", "sequence": "additional", "affiliation": [{"name": "Baltimore, MD"}]}, {"given": "Hiroshi", "family": "Miyamoto", "sequence": "additional", "affiliation": [{"name": "Baltimore, MD"}]}], "member": "276", "container-title": ["Journal of Urology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0022534715031225?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0022534715031225?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 6, 17]], "date-time": "2019-06-17T16:22:56Z", "timestamp": 1560788576000}, "score": 26.348427, "issued": {"date-parts": [[2015, 4]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2015, 4]]}, "issue": "4S"}, "alternative-id": ["10.1016/j.juro.2015.02.2811"], "URL": "http://dx.doi.org/10.1016/j.juro.2015.02.2811", "ISSN": ["0022-5347", "1527-3792"], "issn-type": [{"value": "0022-5347", "type": "print"}, {"value": "1527-3792", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T04:52:27Z", "timestamp": 1574484747091}, "reference-count": 0, "publisher": "American Association for Cancer Research", "content-domain": {"domain": ["aacrjournals.org"], "crossmark-restriction": true}, "published-print": {"date-parts": [[2011, 4, 15]]}, "DOI": "10.1158/1538-7445.am2011-360", "type": "proceedings-article", "created": {"date-parts": [[2012, 6, 27]], "date-time": "2012-06-27T21:11:40Z", "timestamp": 1340831500000}, "update-policy": "http://dx.doi.org/10.1158/aacr-crossmark-policy", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Abstract 360: Effect of adrenogenic androgens on androgen receptor activity in prostate cancer microenvironment"], "prefix": "10.1158", "author": [{"given": "Atsushi", "family": "Mizokami", "sequence": "first", "affiliation": []}, {"given": "Misako", "family": "Kumaki", "sequence": "additional", "affiliation": []}, {"given": "Takashi", "family": "Shima", "sequence": "additional", "affiliation": []}, {"given": "Kouji", "family": "Izumi", "sequence": "additional", "affiliation": []}, {"given": "Yoshifumi", "family": "Kadono", "sequence": "additional", "affiliation": []}, {"given": "Hiroyuki", "family": "Konaka", "sequence": "additional", "affiliation": []}, {"given": "Mikio", "family": "Namiki", "sequence": "additional", "affiliation": []}], "member": "1086", "published-online": {"date-parts": [[2014, 11, 13]]}, "event": {"name": "Proceedings: AACR 102nd Annual Meeting 2011\u2010\u2010 Apr 2\u20106, 2011; Orlando, FL"}, "container-title": ["Endocrinology"], "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1158/1538-7445.AM2011-360", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 18]], "date-time": "2019-05-18T21:49:17Z", "timestamp": 1558216157000}, "score": 25.984814, "issued": {"date-parts": [[2011, 4, 15]]}, "references-count": 0, "alternative-id": ["10.1158/1538-7445.AM2011-360"], "URL": "http://dx.doi.org/10.1158/1538-7445.am2011-360"}, {"indexed": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T18:44:17Z", "timestamp": 1574880257729}, "reference-count": 90, "publisher": "MDPI AG", "issue": "10", "license": [{"URL": "https://creativecommons.org/licenses/by/4.0/", "start": {"date-parts": [[2018, 9, 21]], "date-time": "2018-09-21T00:00:00Z", "timestamp": 1537488000000}, "delay-in-days": 0, "content-version": "unspecified"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Cancers"], "abstract": "<jats:p>Second-generation androgen receptor axis-targeted (ARAT) agents, namely abiraterone and enzalutamide, enable stronger blockade of the androgen receptor (AR) axis and longer survival of men with castration-resistant prostate cancer (CRPC). However, the extent of the improved survival remains insufficient and the majority of patients eventually develop resistance to these novel agents. Some patients develop resistance against ARAT treatment through mechanisms termed \u201ccomplete AR independence\u201d or \u201cAR indifference\u201d, and no longer require activation of the AR axis. However, a considerable proportion of CRPC patients remain persistently dependent on AR or its downstream signaling pathways. Ligand-independent activation of the AR, an AR axis-dependent mechanism, is mediated by truncated forms of ARs that lack the ligand-binding domain (LBD), arising as products of AR splicing variants or nonsense mutations of AR. Post-translational modifications of ARs can also contribute to ligand-independent transactivation of the AR. Other mechanisms for AR axis activation are mediated by pathways that bypass the AR. Recent studies revealed that the glucocorticoid receptor can upregulate a similar transcription program to that of the AR, thus bypassing the AR. ARAT agents are essentially ineffective for CRPC driven by these AR-independent mechanisms. This review article describes recent efforts to overcome these refractory machineries for the development of next-generation AR axis blockade in CRPC.</jats:p>", "DOI": "10.3390/cancers10100345", "type": "journal-article", "created": {"date-parts": [[2018, 9, 21]], "date-time": "2018-09-21T15:00:25Z", "timestamp": 1537542025000}, "page": "345", "source": "Crossref", "is-referenced-by-count": 5, "title": ["Castration-Resistant Prostate Cancer Refractory to Second-Generation Androgen Receptor Axis-Targeted Agents: Opportunities and Challenges"], "prefix": "10.3390", "volume": "10", "author": [{"given": "Yuki", "family": "Kita", "sequence": "first", "affiliation": []}, {"given": "Takayuki", "family": "Goto", "sequence": "additional", "affiliation": []}, {"given": "Shusuke", "family": "Akamatsu", "sequence": "additional", "affiliation": []}, {"given": "Toshinari", "family": "Yamasaki", "sequence": "additional", "affiliation": []}, {"given": "Takahiro", "family": "Inoue", "sequence": "additional", "affiliation": []}, {"given": "Osamu", "family": "Ogawa", "sequence": "additional", "affiliation": []}, {"ORCID": "http://orcid.org/0000-0003-1069-2816", "authenticated-orcid": false, "given": "Takashi", "family": "Kobayashi", "sequence": "additional", "affiliation": []}], "member": "1968", "published-online": {"date-parts": [[2018, 9, 21]]}, "reference": [{"key": "ref1", "DOI": "10.3322/caac.21442", "doi-asserted-by": "publisher"}, {"key": "ref2", "DOI": "10.3390/ijms140815615", "doi-asserted-by": "publisher"}, {"key": "ref3", "DOI": "10.1126/science.1168175", "doi-asserted-by": "publisher"}, {"key": "ref4", "DOI": "10.1016/S0140-6736(10)61389-X", "doi-asserted-by": "publisher"}, {"key": "ref5", "DOI": "10.1056/NEJMoa1207506", "doi-asserted-by": "publisher"}, {"key": "ref6", "DOI": "10.1016/S1470-2045(12)70379-0", "doi-asserted-by": "publisher"}, {"key": "ref7", "DOI": "10.1056/NEJMoa1405095", "doi-asserted-by": "publisher"}, {"key": "ref8", "DOI": "10.1016/S1470-2045(14)71205-7", "doi-asserted-by": "publisher"}, {"key": "ref9", "DOI": "10.1038/nrc4016", "doi-asserted-by": "publisher"}, {"key": "ref10", "DOI": "10.1016/j.eururo.2014.09.049", "doi-asserted-by": "publisher"}, {"key": "ref11", "DOI": "10.1530/ERC-16-0422", "doi-asserted-by": "publisher"}, {"key": "ref12", "DOI": "10.1111/iju.13137", "doi-asserted-by": "publisher"}, {"key": "ref13", "DOI": "10.1007/s11912-017-0593-6", "doi-asserted-by": "publisher"}, {"key": "ref14", "DOI": "10.1158/1078-0432.CCR-11-0728", "doi-asserted-by": "publisher"}, {"key": "ref15", "DOI": "10.2310/JIM.0b013e3181ff6bb8", "doi-asserted-by": "publisher"}, {"key": "ref16", "DOI": "10.1016/j.cell.2013.07.029", "doi-asserted-by": "publisher"}, {"key": "ref17", "DOI": "10.1158/0008-5472.CAN-14-3080", "doi-asserted-by": "publisher"}, {"key": "ref18", "DOI": "10.1158/1535-7163.MCT-16-0186", "doi-asserted-by": "publisher"}, {"key": "ref19", "DOI": "10.1056/NEJM199505253322101", "doi-asserted-by": "publisher"}, {"key": "ref20", "DOI": "10.1038/nm972", "doi-asserted-by": "publisher"}, {"key": "ref21", "DOI": "10.1158/1078-0432.CCR-14-1108", "doi-asserted-by": "publisher"}, {"key": "ref22", "DOI": "10.1158/1078-0432.CCR-14-2666", "doi-asserted-by": "publisher"}, {"key": "ref23", "DOI": "10.1001/jamaoncol.2016.0494", "doi-asserted-by": "publisher"}, {"key": "ref24", "DOI": "10.1126/scitranslmed.aac9511", "doi-asserted-by": "publisher"}, {"key": "ref25", "DOI": "10.1038/bjc.2015.128", "doi-asserted-by": "publisher"}, {"key": "ref26", "DOI": "10.18632/oncotarget.9341", "doi-asserted-by": "publisher"}, {"key": "ref27", "DOI": "10.1158/2159-8290.CD-17-0937", "doi-asserted-by": "publisher"}, {"key": "ref28", "DOI": "10.1158/2159-8290.CD-13-0226", "doi-asserted-by": "publisher"}, {"key": "ref29", "DOI": "10.1158/2159-8290.CD-13-0142", "doi-asserted-by": "publisher"}, {"key": "ref30", "DOI": "10.7554/eLife.00499", "doi-asserted-by": "publisher"}, {"key": "ref31", "DOI": "10.1158/1078-0432.CCR-14-1220", "doi-asserted-by": "publisher"}, {"key": "ref32", "DOI": "10.1126/scitranslmed.3009448", "doi-asserted-by": "publisher"}, {"key": "ref33", "DOI": "10.1158/0008-5472.CAN-11-3948", "doi-asserted-by": "publisher"}, {"key": "ref34", "DOI": "10.1158/0008-5472.CAN-08-0594", "doi-asserted-by": "publisher"}, {"key": "ref35", "DOI": "10.1530/ERC-13-0470", "doi-asserted-by": "publisher"}, {"key": "ref36", "DOI": "10.1158/0008-5472.CAN-08-2764", "doi-asserted-by": "publisher"}, {"key": "ref37", "DOI": "10.1056/NEJMoa1315815", "doi-asserted-by": "publisher"}, {"key": "ref38", "DOI": "10.1038/onc.2013.284", "doi-asserted-by": "publisher"}, {"key": "ref39", "DOI": "10.1158/0008-5472.CAN-10-1998", "doi-asserted-by": "publisher"}, {"key": "ref40", "DOI": "10.1038/onc.2011.637", "doi-asserted-by": "publisher"}, {"key": "ref41", "DOI": "10.1016/j.eururo.2017.01.011", "doi-asserted-by": "publisher"}, {"key": "ref42", "DOI": "10.1038/ncomms13668", "doi-asserted-by": "publisher"}, {"key": "ref43", "DOI": "10.1074/jbc.M112.352930", "doi-asserted-by": "publisher"}, {"key": "ref44", "DOI": "10.1158/0008-5472.CAN-12-3630", "doi-asserted-by": "publisher"}, {"key": "ref45", "DOI": "10.1158/0008-5472.CAN-15-0381", "doi-asserted-by": "publisher"}, {"key": "ref46", "DOI": "10.18632/oncotarget.1802", "doi-asserted-by": "publisher"}, {"key": "ref47", "DOI": "10.1093/nar/gkv262", "doi-asserted-by": "publisher"}, {"key": "ref48", "DOI": "10.1158/1078-0432.CCR-17-0017", "doi-asserted-by": "publisher"}, {"key": "ref49", "DOI": "10.1002/pros.21382", "doi-asserted-by": "publisher"}, {"key": "ref50", "DOI": "10.1073/pnas.1308587110", "doi-asserted-by": "publisher"}, {"key": "ref51", "DOI": "10.1158/0008-5472.CAN-11-3892", "doi-asserted-by": "publisher"}, {"key": "ref52", "DOI": "10.1073/pnas.1012443107", "doi-asserted-by": "publisher"}, {"key": "ref53", "DOI": "10.18632/oncotarget.14296", "doi-asserted-by": "publisher"}, {"key": "ref54", "DOI": "10.1073/pnas.1103904108", "doi-asserted-by": "publisher"}, {"key": "ref55", "DOI": "10.1016/j.ccr.2011.04.008", "doi-asserted-by": "publisher"}, {"key": "ref56", "DOI": "10.1158/1535-7163.MCT-13-0032", "doi-asserted-by": "publisher"}, {"key": "ref57", "DOI": "10.1016/j.eururo.2014.08.006", "doi-asserted-by": "publisher"}, {"key": "ref58", "DOI": "10.1158/1078-0432.CCR-08-0125", "doi-asserted-by": "publisher"}, {"key": "ref59", "DOI": "10.1158/1078-0432.CCR-15-2119", "doi-asserted-by": "publisher"}, {"key": "ref60", "DOI": "10.18632/oncotarget.3084", "doi-asserted-by": "publisher"}, {"key": "ref61", "DOI": "10.1016/j.cell.2013.11.012", "doi-asserted-by": "publisher"}, {"key": "ref62", "DOI": "10.1158/1535-7163.MCT-16-0923", "doi-asserted-by": "publisher"}, {"key": "ref63", "DOI": "10.1210/jc.2012-4000", "doi-asserted-by": "publisher"}, {"key": "ref64", "DOI": "10.1200/JCO.2017.77.6880", "doi-asserted-by": "publisher"}, {"key": "ref65", "DOI": "10.1038/modpathol.2011.7", "doi-asserted-by": "publisher"}, {"key": "ref66", "DOI": "10.1016/j.humpath.2010.05.026", "doi-asserted-by": "publisher"}, {"key": "ref67", "DOI": "10.1038/modpathol.2011.56", "doi-asserted-by": "publisher"}, {"key": "ref68", "DOI": "10.1038/nm.4045", "doi-asserted-by": "publisher"}, {"key": "ref69", "DOI": "10.1126/science.aah4199", "doi-asserted-by": "publisher"}, {"key": "ref70", "DOI": "10.1126/science.aah4307", "doi-asserted-by": "publisher"}, {"key": "ref71", "DOI": "10.1158/2159-8290.CD-16-1174", "doi-asserted-by": "publisher"}, {"key": "ref72", "DOI": "10.1016/j.celrep.2015.07.012", "doi-asserted-by": "publisher"}, {"key": "ref73", "DOI": "10.1056/NEJMoa1715546", "doi-asserted-by": "publisher"}, {"key": "ref74", "DOI": "10.1158/1078-0432.CCR-13-3296", "doi-asserted-by": "publisher"}, {"key": "ref75", "DOI": "10.1158/1535-7163.MCT-17-0259", "doi-asserted-by": "publisher"}, {"key": "ref76", "DOI": "10.1016/j.ccr.2010.04.027", "doi-asserted-by": "publisher"}, {"key": "ref77", "DOI": "10.1080/14656566.2017.1329820", "doi-asserted-by": "publisher"}, {"key": "ref78", "DOI": "10.1158/1535-7163.MCT-14-0521", "doi-asserted-by": "publisher"}, {"key": "ref79", "DOI": "10.1158/1078-0432.CCR-14-0292", "doi-asserted-by": "publisher"}, {"key": "ref80", "DOI": "10.1158/1078-0432.CCR-15-1432", "doi-asserted-by": "publisher"}, {"key": "ref81", "DOI": "10.1371/journal.pone.0198389", "doi-asserted-by": "publisher"}, {"key": "ref82", "DOI": "10.1172/JCI66398", "doi-asserted-by": "publisher"}, {"key": "ref83", "DOI": "10.1016/j.cell.2018.05.037", "doi-asserted-by": "publisher"}, {"key": "ref84", "DOI": "10.1016/j.cell.2018.05.036", "doi-asserted-by": "publisher"}, {"key": "ref85", "DOI": "10.3390/cancers9030022", "doi-asserted-by": "publisher"}, {"key": "ref86", "DOI": "10.1093/annonc/mdy072", "doi-asserted-by": "publisher"}, {"key": "ref87", "DOI": "10.1200/JCO.2017.75.3657", "doi-asserted-by": "publisher"}, {"key": "ref88", "DOI": "10.1056/NEJMoa1702900", "doi-asserted-by": "publisher"}, {"key": "ref89", "DOI": "10.1016/j.eururo.2018.02.001", "doi-asserted-by": "publisher"}, {"key": "ref90", "DOI": "10.1056/NEJMoa1704174", "doi-asserted-by": "publisher"}], "container-title": ["Cancers"], "language": "en", "link": [{"URL": "http://www.mdpi.com/2072-6694/10/10/345/pdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 9, 21]], "date-time": "2018-09-21T15:04:29Z", "timestamp": 1537542269000}, "score": 25.984814, "issued": {"date-parts": [[2018, 9, 21]]}, "references-count": 90, "journal-issue": {"published-online": {"date-parts": [[2018, 10]]}, "issue": "10"}, "alternative-id": ["cancers10100345"], "URL": "http://dx.doi.org/10.3390/cancers10100345", "relation": {"cites": []}, "ISSN": ["2072-6694"], "issn-type": [{"value": "2072-6694", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 12, 2]], "date-time": "2019-12-02T00:08:07Z", "timestamp": 1575245287890}, "reference-count": 50, "publisher": "The Endocrine Society", "issue": "4", "funder": [{"DOI": "10.13039/501100001691", "name": "Japan Society for the Promotion of Science", "doi-asserted-by": "publisher", "award": ["15H04854"]}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2018, 4, 1]]}, "DOI": "10.1210/en.2018-00099", "type": "journal-article", "created": {"date-parts": [[2018, 2, 12]], "date-time": "2018-02-12T19:06:49Z", "timestamp": 1518462409000}, "page": "1774-1792", "source": "Crossref", "is-referenced-by-count": 2, "title": ["Selective Androgen Receptor Modulator S42 Suppresses Prostate Cancer Cell Proliferation"], "prefix": "10.1210", "volume": "159", "author": [{"given": "Takako", "family": "Kawanami", "sequence": "first", "affiliation": [{"name": "Department of Endocrinology and Diabetes Mellitus, Faculty of Medicine, Fukuoka University, Fukuoka, Japan"}]}, {"given": "Tomoko", "family": "Tanaka", "sequence": "additional", "affiliation": [{"name": "Department of Endocrinology and Diabetes Mellitus, Faculty of Medicine, Fukuoka University, Fukuoka, Japan"}, {"name": "Department of Bioregulatory Science of Life-related Diseases, Fukuoka University, Fukuoka, Japan"}]}, {"given": "Yuriko", "family": "Hamaguchi", "sequence": "additional", "affiliation": [{"name": "Department of Endocrinology and Diabetes Mellitus, Faculty of Medicine, Fukuoka University, Fukuoka, Japan"}]}, {"given": "Takashi", "family": "Nomiyama", "sequence": "additional", "affiliation": [{"name": "Department of Endocrinology and Diabetes Mellitus, Faculty of Medicine, Fukuoka University, Fukuoka, Japan"}, {"name": "Department of Bioregulatory Science of Life-related Diseases, Fukuoka University, Fukuoka, Japan"}]}, {"given": "Hajime", "family": "Nawata", "sequence": "additional", "affiliation": [{"name": "Muta Hospital, Fukuoka, Japan"}]}, {"given": "Tosihiko", "family": "Yanase", "sequence": "additional", "affiliation": [{"name": "Department of Endocrinology and Diabetes Mellitus, Faculty of Medicine, Fukuoka University, Fukuoka, Japan"}, {"name": "Department of Bioregulatory Science of Life-related Diseases, Fukuoka University, Fukuoka, Japan"}]}], "member": "80", "published-online": {"date-parts": [[2018, 2, 12]]}, "reference": [{"issue": "1", "key": "2019041122254307000_B1", "doi-asserted-by": "crossref", "first-page": "7", "DOI": "10.3322/canjclin.50.1.7", "article-title": "Cancer statistics, 2000", "volume": "50", "author": "Greenlee", "year": "2000", "journal-title": "CA Cancer J Clin"}, {"key": "2019041122254307000_B2", "author": "The global and regional burden of cancer", "first-page": "16", "year": "2014", "volume-title": "World Cancer Report 2014"}, {"issue": "2", "key": "2019041122254307000_B3", "doi-asserted-by": "crossref", "first-page": "79", "DOI": "10.1016/j.steroids.2003.10.005", "article-title": "The androgen receptor: a potential target for therapy of prostate cancer", "volume": "69", "author": "Santos", "year": "2004", "journal-title": "Steroids"}, {"issue": "6", "key": "2019041122254307000_B4", "doi-asserted-by": "crossref", "first-page": "833", "DOI": "10.1210/er.2004-0013", "article-title": "The decline of androgen levels in elderly men and its clinical and therapeutic implications", "volume": "26", "author": "Kaufman", "year": "2005", "journal-title": "Endocr Rev"}, {"issue": "10", "key": "2019041122254307000_B5", "doi-asserted-by": "crossref", "first-page": "4789", "DOI": "10.1210/jc.2004-0807", "article-title": "Clinical review 171: the rationale, efficacy and safety of androgen therapy in older men: future research and current practice recommendations", "volume": "89", "author": "Liu", "year": "2004", "journal-title": "J Clin Endocrinol Metab"}, {"issue": "4", "key": "2019041122254307000_B6", "doi-asserted-by": "crossref", "first-page": "1000", "DOI": "10.2337/diabetes.54.4.1000", "article-title": "Androgen receptor null male mice develop late-onset obesity caused by decreased energy expenditure and lipolytic activity but show normal insulin sensitivity with high adiponectin secretion", "volume": "54", "author": "Fan", "year": "2005", "journal-title": "Diabetes"}, {"issue": "10", "key": "2019041122254307000_B7", "doi-asserted-by": "crossref", "first-page": "3459", "DOI": "10.1210/jcem.84.10.6122", "article-title": "Selective androgen receptor modulators (SARMs): a novel approach to androgen therapy for the new millennium", "volume": "84", "author": "Negro-Vilar", "year": "1999", "journal-title": "J Clin Endocrinol Metab"}, {"issue": "3", "key": "2019041122254307000_B8", "doi-asserted-by": "crossref", "first-page": "232", "DOI": "10.1097/MCO.0b013e32832a3d79", "article-title": "Selective androgen receptor modulators as function promoting therapies", "volume": "12", "author": "Bhasin", "year": "2009", "journal-title": "Curr Opin Clin Nutr Metab Care"}, {"issue": "12", "key": "2019041122254307000_B9", "doi-asserted-by": "crossref", "first-page": "5606", "DOI": "10.1210/en.2009-0405", "article-title": "A novel synthetic androgen receptor ligand, S42, works as a selective androgen receptor modulator and possesses metabolic effects with little impact on the prostate", "volume": "150", "author": "Min", "year": "2009", "journal-title": "Endocrinology"}, {"issue": "11", "key": "2019041122254307000_B10", "doi-asserted-by": "crossref", "first-page": "3891", "DOI": "10.2337/db13-1169", "article-title": "Exendin-4, a GLP-1 receptor agonist, attenuates prostate cancer growth", "volume": "63", "author": "Nomiyama", "year": "2014", "journal-title": "Diabetes"}, {"issue": "10", "key": "2019041122254307000_B11", "doi-asserted-by": "crossref", "first-page": "e0139709", "DOI": "10.1371/journal.pone.0139709", "article-title": "Combined treatment with Extendin-4 and metformin attenuates prostate cancer growth", "volume": "10", "author": "Tsutsumi", "year": "2015", "journal-title": "PLoS One"}, {"issue": "7", "key": "2019041122254307000_B12", "doi-asserted-by": "crossref", "first-page": "505", "DOI": "10.1038/nrc1387", "article-title": "Insulin-like growth factors and neoplasia", "volume": "4", "author": "Pollak", "year": "2004", "journal-title": "Nat Rev Cancer"}, {"key": "2019041122254307000_B13", "doi-asserted-by": "crossref", "first-page": "7329", "DOI": "10.1074/jbc.M610447200", "article-title": "Insulin-like growth factor 1/insulin signaling activates androgen signaling through direct interactions of Foxo1 with androgen receptor", "volume": "282", "author": "Fan", "year": "2007", "journal-title": "J Biol Chem"}, {"issue": "22", "key": "2019041122254307000_B14", "first-page": "6606", "article-title": "Characterization of a novel androgen receptor mutation in a relapsed CWR22 prostate cancer xenograft and cell line", "volume": "62", "author": "Tepper", "year": "2002", "journal-title": "Cancer Res"}, {"issue": "1", "key": "2019041122254307000_B15", "doi-asserted-by": "crossref", "first-page": "16", "DOI": "10.1158/0008-5472.CAN-08-2764", "article-title": "Ligand-independent androgen receptor variants derived from splicing of cryptic exons signify hormone refractory prostate cancer", "volume": "69", "author": "Hu", "year": "2009", "journal-title": "Cancer Res"}, {"issue": "7", "key": "2019041122254307000_B16", "first-page": "1449", "article-title": "Antiapoptotic signaling in LNCaP prostate cancer cells: a survival signaling pathway independent of phosphatidylinositol 3-kinase and Akt/protein kinase B", "volume": "159", "author": "Jonathan", "year": "1999", "journal-title": "Cancer Res"}, {"issue": "4", "key": "2019041122254307000_B17", "doi-asserted-by": "crossref", "first-page": "1015", "DOI": "10.1158/1078-0432.CCR-11-2189", "article-title": "PTEN deletion in prostate cancer cells does not associate with loss of RAD51 function: implications for radiotherapy and chemotherapy", "volume": "18", "author": "Fraser", "year": "2012", "journal-title": "Clin Cancer Res"}, {"key": "2019041122254307000_B18", "doi-asserted-by": "crossref", "first-page": "169170", "DOI": "10.1155/2012/169170", "article-title": "MAP kinases and prostate cancer", "volume": "2012", "author": "Rodr\u00edguez-Berriguete", "year": "2012", "journal-title": "J Signal Transduct"}, {"issue": "7", "key": "2019041122254307000_B19", "doi-asserted-by": "crossref", "first-page": "3282", "DOI": "10.1210/endo.140.7.6769", "article-title": "Differential posttranscriptional regulation of androgen receptor gene expression by androgen in prostate and breast cancer cells", "volume": "140", "author": "Yeap", "year": "1999", "journal-title": "Endocrinology"}, {"issue": "22", "key": "2019041122254307000_B20", "doi-asserted-by": "crossref", "first-page": "1687", "DOI": "10.1093/jnci/93.22.1687", "article-title": "Androgen receptor signaling in androgen-refractory prostate cancer", "volume": "93", "author": "Grossmann", "year": "2001", "journal-title": "J Natl Cancer Inst"}, {"issue": "4", "key": "2019041122254307000_B21", "doi-asserted-by": "crossref", "first-page": "383", "DOI": "10.1023/A:1006154108619", "article-title": "Insulin-like growth factors and prostate cancer", "volume": "17", "author": "Pollak", "year": "1998", "journal-title": "Cancer Metastasis Rev"}, {"issue": "12", "key": "2019041122254307000_B22", "doi-asserted-by": "crossref", "first-page": "911", "DOI": "10.1093/jnci/90.12.911", "article-title": "Insulin-like growth factor 1 and prostate cancer risk: a population-based, case-control study", "volume": "90", "author": "Wolk", "year": "1998", "journal-title": "J Natl Cancer Inst"}, {"issue": "14", "key": "2019041122254307000_B23", "doi-asserted-by": "crossref", "first-page": "7263", "DOI": "10.1073/pnas.93.14.7263", "article-title": "Antisense RNA to the type I insulin-like growth factor receptor suppresses tumor growth and prevents invasion by rat prostate cancer cells in vivo", "volume": "93", "author": "Burfeind", "year": "1996", "journal-title": "Proc Natl Acad Sci USA"}, {"issue": "16", "key": "2019041122254307000_B24", "first-page": "6276", "article-title": "In vivo progression of LAPC-9 and LNCaP prostate cancer models to androgen independence is associated with increased expression of insulin-like growth factor I (IGF-I) and IGF-I receptor (IGF-IR)", "volume": "61", "author": "Nickerson", "year": "2001", "journal-title": "Cancer Res"}, {"issue": "20", "key": "2019041122254307000_B25", "first-page": "5474", "article-title": "Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor, and epidermal growth factor", "volume": "54", "author": "Culig", "year": "1994", "journal-title": "Cancer Res"}, {"issue": "1-2", "key": "2019041122254307000_B26", "doi-asserted-by": "crossref", "first-page": "105", "DOI": "10.1016/S0303-7207(02)00374-X", "article-title": "Potential action of IGF-1 and EGF on androgen receptor nuclear transfer and transactivation in normal and cancer human prostate cell lines", "volume": "198", "author": "Orio", "year": "2002", "journal-title": "Mol Cell Endocrinol"}, {"issue": "10", "key": "2019041122254307000_B27", "first-page": "2942", "article-title": "Expression of the type 1 insulin-like growth factor receptor is up-regulated in primary prostate cancer and commonly persists in metastatic disease", "volume": "62", "author": "Hellawell", "year": "2002", "journal-title": "Cancer Res"}, {"issue": "1", "key": "2019041122254307000_B28", "doi-asserted-by": "crossref", "first-page": "50", "DOI": "10.1002/path.1492", "article-title": "Blockade of the type I IGF receptor expression in human prostate cancer cells inhibits proliferation and invasion, up-regulates IGF binding protein-3, and suppresses MMP-2 expression", "volume": "202", "author": "Grzmil", "year": "2004", "journal-title": "J Pathol"}, {"issue": "20", "key": "2019041122254307000_B29", "doi-asserted-by": "crossref", "first-page": "7789", "DOI": "10.1073/pnas.0602567103", "article-title": "Progression of prostate cancer by synergy of AKT with genotropic and nongenotropic actions of the androgen receptor", "volume": "103", "author": "Xin", "year": "2006", "journal-title": "Proc Natl Acad Sci U S A"}, {"issue": "17", "key": "2019041122254307000_B30", "first-page": "4291", "article-title": "Loss of PTEN expression in paraffin-embedded primary prostate cancer correlates with high Gleason score and advanced stage", "volume": "59", "author": "McMenamin", "year": "1999", "journal-title": "Cancer Res"}, {"issue": "3", "key": "2019041122254307000_B31", "doi-asserted-by": "crossref", "first-page": "167", "DOI": "10.1097/01.mou.0000165550.94663.fb", "article-title": "Relationship between obesity and prostate cancer", "volume": "15", "author": "Amling", "year": "2005", "journal-title": "Curr Opin Urol"}, {"issue": "1", "key": "2019041122254307000_B32", "doi-asserted-by": "crossref", "first-page": "67", "DOI": "10.1093/jnci/95.1.67", "article-title": "Insulin resistance and prostate cancer risk", "volume": "95", "author": "Hsing", "year": "2003", "journal-title": "J Natl Cancer Inst"}, {"issue": "12", "key": "2019041122254307000_B33", "doi-asserted-by": "crossref", "first-page": "e2037", "DOI": "10.1038/cddis.2015.381", "article-title": "Obesity and cancer, a case for insulin signaling", "volume": "6", "author": "Poloz", "year": "2015", "journal-title": "Cell Death Dis"}, {"issue": "5", "key": "2019041122254307000_B34", "doi-asserted-by": "crossref", "first-page": "1849", "DOI": "10.1158/0008-5472.CAN-04-1837", "article-title": "Androgens up-regulate the insulin-like growth factor-I receptor in prostate cancer cells", "volume": "65", "author": "Pandini", "year": "2005", "journal-title": "Cancer Res"}, {"issue": "5308", "key": "2019041122254307000_B35", "doi-asserted-by": "crossref", "first-page": "1943", "DOI": "10.1126/science.275.5308.1943", "article-title": "PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer", "volume": "275", "author": "Li", "year": "1997", "journal-title": "Science"}, {"issue": "2", "key": "2019041122254307000_B36", "doi-asserted-by": "crossref", "first-page": "655", "DOI": "10.1016/S0002-9440(10)63859-X", "article-title": "Accelerated in vivo growth of prostate tumors that up-regulate interleukin-6 is associated with reduced retinoblastoma protein expression and activation of the mitogen-activated protein kinase pathway", "volume": "162", "author": "Steiner", "year": "2003", "journal-title": "Am J Pathol"}, {"issue": "13", "key": "2019041122254307000_B37", "doi-asserted-by": "crossref", "first-page": "1455", "DOI": "10.1002/pros.21362", "article-title": "The anti-interleukin-6 antibody siltuximab down-regulates genes implicated in tumorigenesis in prostate cancer patients from a phase I study", "volume": "71", "author": "Karkera", "year": "2011", "journal-title": "Prostate"}, {"issue": "9", "key": "2019041122254307000_B38", "first-page": "2206", "article-title": "Constitutive activation of nuclear factor kappaB p50/p65 and Fra-1 and JunD is essential for deregulated interleukin 6 expression in prostate cancer", "volume": "63", "author": "Zerbini", "year": "2003", "journal-title": "Cancer Res"}, {"issue": "1", "key": "2019041122254307000_B39", "doi-asserted-by": "crossref", "first-page": "5", "DOI": "10.1186/1478-811X-2-5", "article-title": "Mitogen activated protein kinase signal transduction pathways in the prostate", "volume": "2", "author": "Maroni", "year": "2004", "journal-title": "Cell Commun Signal"}, {"issue": "4", "key": "2019041122254307000_B40", "first-page": "1008", "article-title": "Disruption of androgen receptor function inhibits proliferation of androgen-refractory prostate cancer cells", "volume": "62", "author": "Zegarra-Moro", "year": "2002", "journal-title": "Cancer Res"}, {"issue": "1", "key": "2019041122254307000_B41", "doi-asserted-by": "crossref", "first-page": "33", "DOI": "10.1038/nm972", "article-title": "Molecular determinants of resistance to antiandrogen therapy", "volume": "10", "author": "Chen", "year": "2004", "journal-title": "Nat Med"}, {"issue": "3-4", "key": "2019041122254307000_B42", "doi-asserted-by": "crossref", "first-page": "207", "DOI": "10.1023/A:1015531326689", "article-title": "Contribution of the androgen receptor to prostate cancer predisposition and progression", "volume": "20", "author": "Buchanan", "year": "2001", "journal-title": "Cancer Metastasis Rev"}, {"issue": "11", "key": "2019041122254307000_B43", "doi-asserted-by": "crossref", "first-page": "464", "DOI": "10.1016/j.urolonc.2015.05.030", "article-title": "Cardiovascular risk with androgen deprivation therapy for prostate cancer: potential mechanisms", "volume": "33", "author": "Tivesten", "year": "2015", "journal-title": "Urol Oncol"}, {"issue": "1", "key": "2019041122254307000_B44", "doi-asserted-by": "crossref", "first-page": "21", "DOI": "10.1188/14.ONF.21-29", "article-title": "Androgen-deprivation therapy and metabolic syndrome in men with prostate cancer", "volume": "41", "author": "Harrington", "year": "2014", "journal-title": "Oncol Nurs Forum"}, {"issue": "8", "key": "2019041122254307000_B45", "doi-asserted-by": "crossref", "first-page": "2088", "DOI": "10.1158/1055-9965.EPI-10-0112", "article-title": "The metabolic syndrome and the risk of prostate cancer under competing risks of death from other causes", "volume": "19", "author": "Grundmark", "year": "2010", "journal-title": "Cancer Epidemiol Biomarkers Prev"}, {"issue": "11", "key": "2019041122254307000_B46", "doi-asserted-by": "crossref", "first-page": "1039", "DOI": "10.1016/S1470-2045(08)70235-3", "article-title": "Prediagnostic body-mass index, plasma C-peptide concentration, and prostate cancer-specific mortality in men with prostate cancer: a long-term survival analysis", "volume": "9", "author": "Ma", "year": "2008", "journal-title": "Lancet Oncol"}, {"key": "2019041122254307000_B47", "doi-asserted-by": "crossref", "first-page": "421", "DOI": "10.1146/annurev-pathol-012615-044359", "article-title": "Obesity, inflammation, and cancer", "volume": "11", "author": "Deng", "year": "2016", "journal-title": "Annu Rev Pathol"}, {"issue": "11", "key": "2019041122254307000_B48", "doi-asserted-by": "crossref", "first-page": "1773", "DOI": "10.1517/14740338.2015.1094052", "article-title": "Comparative safety evaluation of selective androgen receptor modulators and anabolic androgenic steroids", "volume": "14", "author": "Choi", "year": "2015", "journal-title": "Expert Opin Drug Saf"}, {"key": "2019041122254307000_B49", "doi-asserted-by": "crossref", "first-page": "29", "DOI": "10.1016/j.jsbmb.2014.02.005", "article-title": "Identification of an anabolic selective androgen receptor modulator that actively induces death of androgen-independent prostate cancer cells", "volume": "143", "author": "Schmidt", "year": "2014", "journal-title": "J Steroid Biochem Mol Biol"}, {"key": "2019041122254307000_B50", "doi-asserted-by": "crossref", "first-page": "88", "DOI": "10.1016/j.jsbmb.2016.04.007", "article-title": "A novel selective androgen receptor modulator (SARM) MK-4541 exerts anti-androgenic activity in the prostate cancer xenograft R-3327G and anabolic activity on skeletal muscle mass & function in castrated mice", "volume": "163", "author": "Chisamore", "year": "2016", "journal-title": "J Steroid Biochem Mol Biol"}], "container-title": ["Endocrinology"], "language": "en", "link": [{"URL": "http://academic.oup.com/endo/article-pdf/159/4/1774/24398532/en.2018-00099.pdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 4, 12]], "date-time": "2019-04-12T17:00:55Z", "timestamp": 1555088455000}, "score": 25.984814, "issued": {"date-parts": [[2018, 2, 12]]}, "references-count": 50, "journal-issue": {"published-online": {"date-parts": [[2018, 2, 12]]}, "published-print": {"date-parts": [[2018, 4, 1]]}, "issue": "4"}, "URL": "http://dx.doi.org/10.1210/en.2018-00099", "relation": {"cites": []}, "ISSN": ["1945-7170"], "issn-type": [{"value": "1945-7170", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 12, 4]], "date-time": "2019-12-04T04:15:43Z", "timestamp": 1575432943307}, "reference-count": 24, "publisher": "Springer Science and Business Media LLC", "issue": "1", "license": [{"URL": "http://creativecommons.org/licenses/by/4.0/", "start": {"date-parts": [[2019, 4, 8]], "date-time": "2019-04-08T00:00:00Z", "timestamp": 1554681600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": ["link.springer.com"], "crossmark-restriction": false}, "short-container-title": ["BMC Cancer"], "published-print": {"date-parts": [[2019, 12]]}, "DOI": "10.1186/s12885-019-5512-9", "type": "journal-article", "created": {"date-parts": [[2019, 4, 8]], "date-time": "2019-04-08T13:03:47Z", "timestamp": 1554728627000}, "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Androgen receptor mRNA expression is a predictor for recurrence-free survival in non-muscle invasive bladder cancer"], "prefix": "10.1186", "volume": "19", "author": [{"given": "Masato", "family": "Yasui", "sequence": "first", "affiliation": []}, {"given": "Takashi", "family": "Kawahara", "sequence": "additional", "affiliation": []}, {"given": "Koji", "family": "Izumi", "sequence": "additional", "affiliation": []}, {"given": "Masahiro", "family": "Yao", "sequence": "additional", "affiliation": []}, {"given": "Yukari", "family": "Ishiguro", "sequence": "additional", "affiliation": []}, {"given": "Hitoshi", "family": "Ishiguro", "sequence": "additional", "affiliation": []}, {"given": "Hiroji", "family": "Uemura", "sequence": "additional", "affiliation": []}, {"ORCID": "http://orcid.org/0000-0001-8857-9798", "authenticated-orcid": false, "given": "Yasuhide", "family": "Miyoshi", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2019, 4, 8]]}, "reference": [{"key": "5512_CR1", "doi-asserted-by": "publisher", "first-page": "87", "DOI": "10.3322/caac.21262", "volume": "65", "author": "BF Torre LA", "year": "2015", "unstructured": "Torre LA BF, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87\u2013108.", "journal-title": "CA Cancer J Clin"}, {"key": "5512_CR2", "doi-asserted-by": "publisher", "first-page": "884", "DOI": "10.1093/jjco/hyv088", "volume": "45", "author": "HM MT", "year": "2015", "unstructured": "MT HM, Shibata A, Katanoda K, Sobue T, Nishimoto H. Japan Cancer surveillance research group. Cancer incidence and incidence rates in Japan in 2009: a study of 32 population-based cancer registries for the monitoring of Cancer incidence in Japan (MCIJ) project. Jpn J Clin Oncol. 2015;45:884\u201391.", "journal-title": "Jpn J Clin Oncol"}, {"issue": "12", "key": "5512_CR3", "doi-asserted-by": "publisher", "first-page": "20", "DOI": "10.3390/cancers9020020", "volume": "9", "author": "Peng Li", "year": "2017", "unstructured": "Li PCJ, Miyamoto H. Androgen receptor signaling in bladder Cancer. Cancers (Basel). 2017;9. \n                    https://doi.org/10.3390/cancers9020020\n                    \n                  .", "journal-title": "Cancers"}, {"key": "5512_CR4", "doi-asserted-by": "publisher", "first-page": "569", "DOI": "10.1093/jjco/hys072", "volume": "42", "author": "YIK Li", "year": "2012", "unstructured": "Li YIK, Miyamoto H. The role of the androgen receptor in the development and progression of bladder cancer. Jpn J Clin Oncol. 2012;42:569\u201377.", "journal-title": "Jpn J Clin Oncol"}, {"key": "5512_CR5", "doi-asserted-by": "publisher", "first-page": "1", "DOI": "10.1155/2015/384860", "volume": "2015", "author": "Lucien McBeth", "year": "2015", "unstructured": "McBeth L GM, Selman S, Hinds TD Jr. Involvement of the androgen and glucocorticoid receptors in bladder Cancer. Int J Endocrinol 2015. \n                    https://doi.org/10.1155/2015/384860\n                    \n                  .", "journal-title": "International Journal of Endocrinology"}, {"issue": "4", "key": "5512_CR6", "first-page": "150", "volume": "12", "author": "AHAM Rahmani", "year": "2013", "unstructured": "Rahmani AHAM, Babiker AY, Khan AA, Aly SM, Rizvi MA. Implication of androgen receptor in urinary bladder cancer: a critical mini review. Int J Mol Epidemiol Genet. 2013;12(4):150\u20135.", "journal-title": "Int J Mol Epidemiol Genet"}, {"key": "5512_CR7", "doi-asserted-by": "publisher", "first-page": "R265", "DOI": "10.1530/ERC-15-0209", "volume": "22", "author": "APMM Lombard", "year": "2015", "unstructured": "Lombard APMM. The emerging role of the androgen receptor in bladder cancer. Endocr Relat Cancer. 2015;22:R265\u201377.", "journal-title": "Endocr Relat Cancer"}, {"key": "5512_CR8", "doi-asserted-by": "publisher", "first-page": "73", "DOI": "10.1007/BF00256185", "volume": "3", "author": "EHT Okajima", "year": "1975", "unstructured": "Okajima EHT, Iriya K, Ijuin M, Matsushima S. Effects of sex hormones on development of urinary bladder tumours in rats induced by N-butyl-N-(4-hydroxybutyl) nitrosamine. Urol Res. 1975;3:73\u20139.", "journal-title": "Urol Res"}, {"key": "5512_CR9", "doi-asserted-by": "publisher", "first-page": "105", "DOI": "10.1159/000292737", "volume": "34", "author": "SSN Terada", "year": "1992", "unstructured": "Terada SSN, Uchide K, Akasofu K, Nishida E. Effect of testosterone on the development of bladder tumors and calculi in female rats. Gynecol Obstet Investig. 1992;34:105\u201310.", "journal-title": "Gynecol Obstet Investig"}, {"key": "5512_CR10", "doi-asserted-by": "publisher", "first-page": "360", "DOI": "10.1159/000474484", "volume": "31", "author": "SAH Imada", "year": "1997", "unstructured": "Imada SAH, Ami Y, Koiso K, Ideyama Y, Takenaka T. Promoting effects and mechanisms of action of androgen in bladder carcinogenesis in male rats. Eur Urol. 1997;31:360\u20134.", "journal-title": "Eur Urol"}, {"issue": "99", "key": "5512_CR11", "doi-asserted-by": "publisher", "first-page": "558", "DOI": "10.1093/jnci/djk113", "volume": "4", "author": "HYZ Miyamoto", "year": "2007", "unstructured": "Miyamoto HYZ, Chen YT, Ishiguro H, Uemura H, Kubota Y, Nagashima Y, Chang YJ, Hu YC, Tsai MY, Yeh S, Messing EM, Chang C. Promotion of bladder cancer development and progression by androgen receptor signals. J Natl Cancer Inst. 2007;4(99):558\u201368.", "journal-title": "J Natl Cancer Inst"}, {"key": "5512_CR12", "doi-asserted-by": "publisher", "first-page": "1811", "DOI": "10.1016/j.ajpath.2013.01.018", "volume": "182", "author": "JWHI Hsu", "year": "2013", "unstructured": "Hsu JWHI, Xu D, Miyamoto H, Liang L, Wu XR, Shyr CR, Chang C. Decreased tumorigenesis and mortality from bladder Cancer in mice lacking urothelial androgen receptor. Am J Pathol. 2013;182:1811\u201320.", "journal-title": "Am J Pathol"}, {"key": "5512_CR13", "doi-asserted-by": "publisher", "first-page": "1214", "DOI": "10.3349/ymj.2014.55.5.1214", "volume": "55", "author": "JKPS Nam", "year": "2014", "unstructured": "Nam JKPS, Lee SD, Chung MK. Prognostic value of sex-hormone receptor expression in non-muscle-invasive bladder cancer. Yonsei Med J. 2014;55:1214\u201321.", "journal-title": "Yonsei Med J"}, {"key": "5512_CR14", "doi-asserted-by": "publisher", "first-page": "1716", "DOI": "10.1111/j.1464-410X.2011.10706.x", "volume": "109", "author": "HYJ Miyamoto", "year": "2012", "unstructured": "Miyamoto HYJ, Chaux A, Zheng Y, Hsu I, Izumi K, Chang C, Messing EM, Netto GJ, Yeh S. Expression of androgen and oestrogen receptors and its prognostic significance in urothelial neoplasm of the urinary bladder. BJU Int. 2012;109:1716\u201326.", "journal-title": "BJU Int"}, {"key": "5512_CR15", "doi-asserted-by": "publisher", "first-page": "340", "DOI": "10.1016/j.tranon.2017.01.013", "volume": "10", "author": "DBJ Sikic", "year": "2017", "unstructured": "Sikic DBJ, Hartmann A, Burger M, Erben P, Denzinger S, Eckstein M, St\u00f6hr R, Wach S, Wullich B, Keck B, Wirtz RM, Otto W. High androgen receptor mRNA expression is independently associated with prolonged Cancer-specific and recurrence-free survival in stage T1 bladder Cancer. Transl Oncol. 2017;10:340\u20135.", "journal-title": "Transl Oncol"}, {"key": "5512_CR16", "doi-asserted-by": "publisher", "first-page": "12665", "DOI": "10.18632/oncotarget.2851", "volume": "5", "author": "KTM Izumi", "year": "2014", "unstructured": "Izumi KTM, Miyamoto H, Hara Y, Kishida T, Chiba K, Murai T, Hirai K, Suzuki K, Fujinami K, Ueki T, Udagawa K, Kitami K, Moriyama M, Miyoshi Y, Tsuchiya F, Ikeda I, Kobayashi K, Sato M, Morita S, Noguchi K, Uemura H. Androgen deprivation therapy prevents bladder cancer recurrence. Oncotarget. 2014;5:12665\u201374.", "journal-title": "Oncotarget"}, {"key": "5512_CR17", "doi-asserted-by": "publisher", "first-page": "432.e15", "DOI": "10.1016/j.urolonc.2016.05.016", "volume": "34", "author": "TIH Kawahara", "year": "2016", "unstructured": "Kawahara TIH, Kashiwagi E, El-Shishtawy KA, Li Y, Reis LO, Zheng Y, Miyamoto H. Enzalutamide inhibits androgen receptor-positive bladder cancer cell growth. Urol Oncol. 2016;34:432.e15\u201323.", "journal-title": "Urol Oncol"}, {"key": "5512_CR18", "doi-asserted-by": "publisher", "first-page": "2009", "DOI": "10.1097/01.ju.0000092238.15685.10", "volume": "170", "author": "FLP Chen", "year": "2003", "unstructured": "Chen FLP, Zhang G, Iwamoto Y, See W. Androgen dependent regulation of bacillus Calmette-Guerin induced interleukin-6 expression in human transitional carcinoma cell lines. J Urol. 2003;170:2009\u201313.", "journal-title": "J Urol"}, {"key": "5512_CR19", "author": "KF Budczies J", "volume": "7", "year": "2012", "unstructured": "Budczies J KF, Sinn BV, Gy\u0151rffy B, Schmitt WD, Darb-Esfahani S, Denkert C. Cutoff finder: a comprehensive and straightforward web application enabling rapid biomarker cutoff optimization. PLoS One. 2012;7:e51862.", "journal-title": "PLoS One", "DOI": "10.1371/journal.pone.0051862", "doi-asserted-by": "publisher"}, {"key": "5512_CR20", "doi-asserted-by": "publisher", "first-page": "3225", "DOI": "10.1038/onc.2013.274", "volume": "19", "author": "CLS Chang", "year": "2014", "unstructured": "Chang CLS, Yeh S, Chang TM. Androgen receptor (AR) differential roles in hormone-related tumors including prostate, bladder, kidney, lung, breast and liver. Oncogene. 2014;19:3225\u201334.", "journal-title": "Oncogene"}, {"key": "5512_CR21", "first-page": "3", "volume": "37", "author": "RAGM Davey", "year": "2016", "unstructured": "Davey RAGM. Androgen receptor structure, function and biology: from bench to bedside. Clin Biochem Rev. 2016;37:3\u201315.", "journal-title": "Clin Biochem Rev"}, {"key": "5512_CR22", "doi-asserted-by": "publisher", "first-page": "674", "DOI": "10.1016/S0022-5347(05)66041-7", "volume": "166", "author": "SSR Salmi", "year": "2001", "unstructured": "Salmi SSR, Gustafsson JA, M\u00e4kel\u00e4 S. Co-localization of androgen receptor with estrogen receptor beta in the lower urinary tract of the male rat. J Urol. 2001;166:674\u20137.", "journal-title": "J Urol"}, {"key": "5512_CR23", "doi-asserted-by": "publisher", "first-page": "1913", "DOI": "10.1016/j.juro.2014.01.012", "volume": "191", "author": "LMYY Shortliffe", "year": "2014", "unstructured": "Shortliffe LMYY, Behr B, Wang B. Testosterone changes bladder and kidney structure in juvenile male rats. J Urol. 2014;191:1913\u20139.", "journal-title": "J Urol"}, {"key": "5512_CR24", "unstructured": "Inoue SMT, Miyamoto H. Role of the androgen receptor in urothelial cancer. Mol Cell Endocrinol. 2017."}], "container-title": ["BMC Cancer"], "language": "en", "link": [{"URL": "http://link.springer.com/content/pdf/10.1186/s12885-019-5512-9.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/article/10.1186/s12885-019-5512-9/fulltext.html", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/content/pdf/10.1186/s12885-019-5512-9.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 4, 8]], "date-time": "2019-04-08T13:07:13Z", "timestamp": 1554728833000}, "score": 25.422646, "issued": {"date-parts": [[2019, 4, 8]]}, "references-count": 24, "journal-issue": {"published-print": {"date-parts": [[2019, 12]]}, "issue": "1"}, "alternative-id": ["5512"], "URL": "http://dx.doi.org/10.1186/s12885-019-5512-9", "relation": {"cites": []}, "ISSN": ["1471-2407"], "issn-type": [{"value": "1471-2407", "type": "electronic"}], "subject": ["Genetics", "Cancer Research", "Oncology"], "assertion": [{"value": "24 November 2017", "order": 1, "name": "received", "label": "Received", "group": {"name": "ArticleHistory", "label": "Article History"}}, {"value": "25 March 2019", "order": 2, "name": "accepted", "label": "Accepted", "group": {"name": "ArticleHistory", "label": "Article History"}}, {"value": "8 April 2019", "order": 3, "name": "first_online", "label": "First Online", "group": {"name": "ArticleHistory", "label": "Article History"}}, {"value": "IRB approval for Yokohama City University. Informed consent was obtained in the form of opt-out on the web-site. Those who rejected were excluded.", "order": 1, "name": "Ethics", "group": {"name": "EthicsHeading", "label": "Ethics approval and consent to participate"}}, {"value": "Not applicable.", "order": 2, "name": "Ethics", "group": {"name": "EthicsHeading", "label": "Consent for publication"}}, {"value": "The authors declare that they have no competing interests.", "order": 3, "name": "Ethics", "group": {"name": "EthicsHeading", "label": "Competing interests"}}, {"value": "Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.", "order": 4, "name": "Ethics", "group": {"name": "EthicsHeading", "label": "Publisher\u2019s Note"}}], "article-number": "331"}, {"indexed": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T15:18:18Z", "timestamp": 1574867898222}, "reference-count": 35, "publisher": "Wiley", "issue": "3", "license": [{"URL": "http://onlinelibrary.wiley.com/termsAndConditions#vor", "start": {"date-parts": [[2017, 12, 1]], "date-time": "2017-12-01T00:00:00Z", "timestamp": 1512086400000}, "delay-in-days": 0, "content-version": "vor"}, {"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2017, 12, 1]], "date-time": "2017-12-01T00:00:00Z", "timestamp": 1512086400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Prostate"], "published-print": {"date-parts": [[2018, 2]]}, "DOI": "10.1002/pros.23460", "type": "journal-article", "created": {"date-parts": [[2017, 12, 1]], "date-time": "2017-12-01T09:26:45Z", "timestamp": 1512120405000}, "page": "222-232", "source": "Crossref", "is-referenced-by-count": 0, "title": ["A carbon 21 steroidal metabolite from progestin, 20\u03b2\u2010hydroxy\u20105\u03b1\u2010dihydroprogesterone, stimulates the androgen receptor in prostate cancer cells"], "prefix": "10.1002", "volume": "78", "author": [{"ORCID": "http://orcid.org/0000-0002-9035-4798", "authenticated-orcid": false, "given": "Takashi", "family": "Ando", "sequence": "first", "affiliation": [{"name": "Department of Regenerative and Transplant MedicineNiigata University Graduate School of Medical and Dental SciencesNiigataNiigataJapan"}]}, {"given": "Tsutomu", "family": "Nishiyama", "sequence": "additional", "affiliation": [{"name": "Department of Regenerative and Transplant MedicineNiigata University Graduate School of Medical and Dental SciencesNiigataNiigataJapan"}]}, {"given": "Itsuhiro", "family": "Takizawa", "sequence": "additional", "affiliation": [{"name": "Department of Regenerative and Transplant MedicineNiigata University Graduate School of Medical and Dental SciencesNiigataNiigataJapan"}]}, {"given": "Yoshimichi", "family": "Miyashiro", "sequence": "additional", "affiliation": [{"name": "ASKA Pharmaceutical Medical Co. Ltd.KawasakiKanagawaJapan"}]}, {"given": "Noboru", "family": "Hara", "sequence": "additional", "affiliation": [{"name": "Department of Regenerative and Transplant MedicineNiigata University Graduate School of Medical and Dental SciencesNiigataNiigataJapan"}]}, {"given": "Yoshihiko", "family": "Tomita", "sequence": "additional", "affiliation": [{"name": "Department of Regenerative and Transplant MedicineNiigata University Graduate School of Medical and Dental SciencesNiigataNiigataJapan"}]}], "member": "311", "published-online": {"date-parts": [[2017, 12]]}, "reference": [{"key": "e_1_2_7_2_1", "first-page": "5", "article-title": "Cancer statistics", "volume": "2015", "author": "Siegel RL", "year": "2015", "journal-title": "Cancer J Clin"}, {"key": "e_1_2_7_3_1", "doi-asserted-by": "crossref", "first-page": "830", "DOI": "10.1111/j.1442-2042.2010.02613.x", "article-title": "Updated Japanese urological association guidelines on prostate\u2010specific antigen\u2010based screening for prostate cancer in 2010", "volume": "17", "author": "Naito S", "year": "2010", "journal-title": "Int J Urol"}, {"key": "e_1_2_7_4_1", "doi-asserted-by": "crossref", "first-page": "1220", "DOI": "10.1016/S0022-5347(01)62501-1", "article-title": "Management of hormone refractory prostate cancer: current standards and future prospects", "volume": "160", "author": "Oh WK", "year": "1998", "journal-title": "J Urol"}, {"key": "e_1_2_7_5_1", "first-page": "67", "article-title": "Androgen biosynthesis in castration\u2010resistant prostate cancer", "volume": "4", "author": "Trevor MP", "year": "2014", "journal-title": "Endocr Relat Cancer"}, {"key": "e_1_2_7_6_1", "doi-asserted-by": "crossref", "first-page": "4447", "DOI": "10.1158/0008-5472.CAN-08-0249", "article-title": "Maintenance of intratumoral androgens in metastatic prostate cancer: a mechanism for castration\u2010resistant tumor growth", "volume": "68", "author": "Montgomery RB", "year": "2008", "journal-title": "Cancer Res"}, {"key": "e_1_2_7_7_1", "first-page": "274", "article-title": "The PREVAIL Study: primary outcomes by site and extent of baseline disease for enzalutamide\u2010treated men with chemotherapy\u2010na\u00efve metastatic castration\u2010resistant prostate cancer", "volume": "16", "author": "Evans CP", "year": "2016", "journal-title": "Eur Urol"}, {"key": "e_1_2_7_8_1", "first-page": "1002", "article-title": "Prior endocrine therapy impact on abiraterone acetate clinical efficacy in metastatic castration\u2010resistant prostate cancer: post\u2010hoc analysis of randomised phase 3 studies", "volume": "15", "author": "Bellmunt J", "year": "2015", "journal-title": "Eur Urol"}, {"key": "e_1_2_7_9_1", "doi-asserted-by": "crossref", "first-page": "72", "DOI": "10.1007/s12672-014-0173-2", "article-title": "Glucocorticoid receptor activity contributes to resistance to androgen\u2010targeted therapy in prostate cancer", "volume": "2", "author": "Isikbay M", "year": "2014", "journal-title": "Horm Cancer"}, {"key": "e_1_2_7_10_1", "doi-asserted-by": "crossref", "first-page": "1897", "DOI": "10.1111/j.1349-7006.2010.01620.x", "article-title": "5\u03b1DH\u2010DOC (5\u03b1\u2010dihydro\u2010deoxycorticosterone) activates androgen receptor in castration\u2010resistant prostate cancer", "volume": "8", "author": "Uemura M", "year": "2010", "journal-title": "Cancer Sci"}, {"key": "e_1_2_7_11_1", "doi-asserted-by": "crossref", "first-page": "1309", "DOI": "10.1016/j.cell.2013.11.012", "article-title": "Glucocorticoid receptor confers resistance to antiandrogens by bypassing androgen receptor blockade", "volume": "6", "author": "Arora VK", "year": "2013", "journal-title": "Cell"}, {"key": "e_1_2_7_12_1", "doi-asserted-by": "crossref", "first-page": "703", "DOI": "10.1038/76287", "article-title": "Glucocorticoids can promote androgen\u2010independent growth of prostate cancer cells through a mutated androgen receptor", "volume": "6", "author": "Zhao XY", "year": "2000", "journal-title": "Nat Med"}, {"key": "e_1_2_7_13_1", "doi-asserted-by": "crossref", "first-page": "3705", "DOI": "10.1200/JCO.2013.53.4578", "article-title": "Intense androgen\u2010deprivation therapy with abiraterone acetate plus leuprolide acetate in patients with localized high\u2010risk prostate cancer: results of a randomized phase II neoadjuvant study", "volume": "33", "author": "Taplin ME", "year": "2014", "journal-title": "Clin Oncol"}, {"key": "e_1_2_7_14_1", "doi-asserted-by": "crossref", "first-page": "507", "DOI": "10.1210/jc.2011-2189", "article-title": "Clinical and biochemical consequences of CYP17A1 inhibition with abiraterone given with and without exogenous glucocorticoids in castrate men with advanced prostate cancer", "volume": "2", "author": "Attard G", "year": "2012", "journal-title": "J Clin Endocrinol Metab"}, {"key": "e_1_2_7_15_1", "doi-asserted-by": "crossref", "first-page": "236", "DOI": "10.1016/j.ijrobp.2015.01.020", "article-title": "External beam radiation therapy and abiraterone in men with localized prostate cancer: safety and effect on tissue androgens", "volume": "92", "author": "Cho E", "year": "2015", "journal-title": "Int J Radiat Oncol Biol Phys"}, {"key": "e_1_2_7_16_1", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1016/S0960-0760(00)00131-X", "article-title": "Pregnenolone stimulates LNCaP prostate cancer cell growth via the mutated androgen receptor", "volume": "1", "author": "Grigoryev DN", "year": "2000", "journal-title": "J Steroid Biochem Mol Biol"}, {"key": "e_1_2_7_17_1", "doi-asserted-by": "crossref", "first-page": "317", "DOI": "10.1016/0022-4731(89)90270-7", "article-title": "Identification of 20 alpha\u2010hydroxy\u20105 alpha\u2010pregnan\u20103\u2010one and 20 beta\u2010hydroxy\u20105 alpha\u2010pregnan\u20103\u2010one in human pregnancy urine", "volume": "32", "author": "Philip A", "year": "1989", "journal-title": "J Steroid Biochem"}, {"key": "e_1_2_7_18_1", "doi-asserted-by": "crossref", "first-page": "297", "DOI": "10.1016/j.cbi.2014.11.012", "article-title": "Important roles of the AKR1C2 and SRD5A1 enzymes in progesterone metabolism in endometrial cancer model cell lines", "volume": "5", "author": "Sinreih M", "year": "2015", "journal-title": "Chem\u2010Biol Interact"}, {"key": "e_1_2_7_19_1", "doi-asserted-by": "crossref", "first-page": "441", "DOI": "10.1248/bpb.25.441", "article-title": "Substrate specificity of human 3(20)alpha\u2010hydroxysteroid dehydrogenase for neurosteroids and its inhibition by benzodiazepines", "volume": "25", "author": "Usami N", "year": "2002", "journal-title": "Biol Pharm Bull"}, {"key": "e_1_2_7_20_1", "first-page": "13451", "article-title": "Pig testicular 20\u03b2\u2010hydroxysteroid dehydrogenase exhibits carbonyl reductase\u2010like structure and activity", "volume": "19", "author": "Tanaka M", "year": "1992", "journal-title": "J Biol Chem"}, {"key": "e_1_2_7_21_1", "doi-asserted-by": "crossref", "first-page": "243", "DOI": "10.1016/j.beem.2008.01.003", "article-title": "Intracrine androgen metabolism in prostate cancer progression: mechanisms of castration resistance and therapeutic implications", "volume": "2", "author": "Mostaghel EA", "year": "2008", "journal-title": "Best Pract Res, Clin Endocrinol Metab"}, {"key": "e_1_2_7_22_1", "doi-asserted-by": "crossref", "first-page": "432", "DOI": "10.1016/j.tem.2004.09.004", "article-title": "The backdoor pathway to dihydrotestosterone", "volume": "9", "author": "Auchus RJ", "year": "2004", "journal-title": "Trends Endocrinol Metab"}, {"key": "e_1_2_7_23_1", "doi-asserted-by": "crossref", "first-page": "13728", "DOI": "10.1073/pnas.1107898108", "article-title": "Dihydrotestosterone synthesis bypasses testosterone to drive castration\u2010resistant prostate cancer", "volume": "108", "author": "Chang KH", "year": "2011", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "e_1_2_7_24_1", "doi-asserted-by": "crossref", "first-page": "444", "DOI": "10.1210/me.2005-0287", "article-title": "Identification of the major oxidative 3\u03b1\u2010hydroxysteroid dehydrogenase in human prostate that converts 5\u03b1\u2010androstane\u20103\u03b1,17\u03b2\u2010diol to 5\u03b1\u2010dihydrotestosterone: a potential therapeutic target for androgen\u2010dependent disease", "volume": "20", "author": "Bauman DR", "year": "2006", "journal-title": "Mol Endocrinol"}, {"key": "e_1_2_7_25_1", "first-page": "1636", "article-title": "Intratumoral conversion of adrenal androgen precursors drives androgen receptor\u2010activated cell growth in prostate cancer more potently than de novo steroidogenesis", "volume": "15", "author": "Kumagai J", "year": "2013", "journal-title": "Prostate"}, {"key": "e_1_2_7_26_1", "doi-asserted-by": "crossref", "first-page": "1256", "DOI": "10.1158/0008-5472.CAN-09-2092", "article-title": "Evidence of limited contributions for intratumoral steroidogenesis in prostate cancer", "volume": "3", "author": "Hofland J", "year": "2010", "journal-title": "Cancer Res"}, {"key": "e_1_2_7_27_1", "doi-asserted-by": "crossref", "first-page": "185", "DOI": "10.1677/jme.0.0260185", "article-title": "Expression and role of functional glucocorticoid receptors in the human androgen\u2010independent prostate cancer cell line, DU145", "volume": "26", "author": "Dondi D", "year": "2001", "journal-title": "J Mol Endocrinol"}, {"key": "e_1_2_7_28_1", "first-page": "163", "article-title": "VCaP, a cell\u2010based model system of human prostate cancer", "volume": "15", "author": "Korenchuk S", "year": "2001", "journal-title": "In Vivo"}, {"key": "e_1_2_7_29_1", "doi-asserted-by": "crossref", "first-page": "534", "DOI": "10.1016/S0006-291X(05)80067-1", "article-title": "A mutation in the ligand binding domain of the androgen receptor of human LNCaP cells affects steroid binding characteristics and response to anti\u2010androgens", "volume": "173", "author": "Veldscholte J", "year": "1990", "journal-title": "Biochem Biophys Res Commun"}, {"key": "e_1_2_7_30_1", "doi-asserted-by": "crossref", "first-page": "244", "DOI": "10.1016/j.eururo.2007.10.052", "article-title": "Type 1 and type 2 5alpha\u2010reductase expression in the development and progression of prostate cancer", "volume": "53", "author": "Thomas LN", "year": "2008", "journal-title": "Eur Urol"}, {"key": "e_1_2_7_31_1", "doi-asserted-by": "crossref", "first-page": "1023", "DOI": "10.1016/j.juro.2014.09.021", "article-title": "Dutasteride and enzalutamide synergistically suppress prostate tumor cell proliferation", "volume": "3", "author": "Hamid AR", "year": "2015", "journal-title": "J Urol"}, {"key": "e_1_2_7_32_1", "doi-asserted-by": "crossref", "first-page": "235", "DOI": "10.1002/pros.22745", "article-title": "5\u03b1\u2010reductase type 3 enzyme in benign and malignant prostate", "volume": "74", "author": "Titus MA", "year": "2014", "journal-title": "Prostate"}, {"key": "e_1_2_7_33_1", "doi-asserted-by": "crossref", "first-page": "e77407", "DOI": "10.1371/journal.pone.0077407", "article-title": "Characterization of prostate cancer bone metastases according to expression levels of steroidogenic enzymes and androgen receptor splice variants", "volume": "11", "author": "Jernberg E", "year": "2013", "journal-title": "PLoS ONE"}, {"key": "e_1_2_7_34_1", "doi-asserted-by": "crossref", "first-page": "135", "DOI": "10.1196/annals.1336.015", "article-title": "Determining structure and function of steroid dehydrogenase enzymes by sequence analysis, homology modeling, and rational mutational analysis", "volume": "1061", "author": "Duax WL", "year": "2005", "journal-title": "Ann N Y Acad Sci"}, {"key": "e_1_2_7_35_1", "doi-asserted-by": "crossref", "first-page": "85", "DOI": "10.1248/yakushi.121.85", "article-title": "Strain\u2010, sex\u2010 and species\u2010related differences of acetohexamide reductase and 20\u03b2\u2010hydroxysteroid dehydrogenase activities in liver microsomes of experimental animals", "volume": "1", "author": "Imamura Y", "year": "2001", "journal-title": "Yakugaku Zasshi"}, {"key": "e_1_2_7_36_1", "doi-asserted-by": "crossref", "first-page": "2075", "DOI": "10.1016/S0024-3205(00)00793-1", "article-title": "Further studies on 20\u03b2\u2010hydroxysteroid dehydrogenase with carbonyl reductase\u2010like activity present in liver microsomes of male rats", "volume": "17", "author": "Takada H", "year": "2000", "journal-title": "Life Sci"}], "container-title": ["The Prostate"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fpros.23460", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://onlinelibrary.wiley.com/doi/pdf/10.1002/pros.23460", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://onlinelibrary.wiley.com/doi/full-xml/10.1002/pros.23460", "content-type": "application/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://onlinelibrary.wiley.com/doi/pdf/10.1002/pros.23460", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 4, 17]], "date-time": "2019-04-17T00:47:22Z", "timestamp": 1555462042000}, "score": 25.198833, "issued": {"date-parts": [[2017, 12]]}, "references-count": 35, "journal-issue": {"published-online": {"date-parts": [[2017, 11, 22]]}, "published-print": {"date-parts": [[2018, 2]]}, "issue": "3"}, "alternative-id": ["10.1002/pros.23460"], "URL": "http://dx.doi.org/10.1002/pros.23460", "archive": ["Portico"], "relation": {"cites": []}, "ISSN": ["0270-4137", "1097-0045"], "issn-type": [{"value": "0270-4137", "type": "print"}, {"value": "1097-0045", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T14:46:54Z", "timestamp": 1574779614029}, "reference-count": 0, "publisher": "Ovid Technologies (Wolters Kluwer Health)", "issue": "4S", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2016, 4, 1]], "date-time": "2016-04-01T00:00:00Z", "timestamp": 1459468800000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Journal of Urology"], "published-print": {"date-parts": [[2016, 4]]}, "DOI": "10.1016/j.juro.2016.02.2435", "type": "journal-article", "created": {"date-parts": [[2016, 3, 28]], "date-time": "2016-03-28T07:15:47Z", "timestamp": 1459149347000}, "source": "Crossref", "is-referenced-by-count": 0, "title": ["MP88-17 IMMUNOHISTOCHEMISTRY OF ANDROGEN RECEPTOR AND ESTROGEN RECEPTOR-\u03b2 IN BLADDER CANCER AS PREDICTORS OF CHEMOSENSITIVITY"], "prefix": "10.1097", "volume": "195", "author": [{"given": "Eiji", "family": "Kashiwagi", "sequence": "first", "affiliation": [{"name": "Baltimore, MD"}]}, {"given": "Hiroki", "family": "Ide", "sequence": "additional", "affiliation": [{"name": "Baltimore, MD"}]}, {"given": "Takashi", "family": "Kawahara", "sequence": "additional", "affiliation": [{"name": "Baltimore, MD"}]}, {"given": "Satoshi", "family": "Inoue", "sequence": "additional", "affiliation": [{"name": "Baltimore, MD"}]}, {"given": "Mehsa", "family": "Jalalizadeh", "sequence": "additional", "affiliation": [{"name": "Baltimore, MD"}]}, {"given": "George", "family": "Netto", "sequence": "additional", "affiliation": [{"name": "Baltimore, MD"}]}, {"given": "Alexander", "family": "Baras", "sequence": "additional", "affiliation": [{"name": "Baltimore, MD"}]}, {"given": "Hiroshi", "family": "Miyamoto", "sequence": "additional", "affiliation": [{"name": "Baltimore, MD"}]}], "member": "276", "container-title": ["Journal of Urology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0022534716027233?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0022534716027233?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 6, 17]], "date-time": "2019-06-17T17:23:50Z", "timestamp": 1560792230000}, "score": 24.996674, "issued": {"date-parts": [[2016, 4]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2016, 4]]}, "issue": "4S"}, "alternative-id": ["10.1016/j.juro.2016.02.2435"], "URL": "http://dx.doi.org/10.1016/j.juro.2016.02.2435", "ISSN": ["0022-5347", "1527-3792"], "issn-type": [{"value": "0022-5347", "type": "print"}, {"value": "1527-3792", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T07:41:35Z", "timestamp": 1574408495737}, "reference-count": 31, "publisher": "Wiley", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 2069, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Prostate"], "published-print": {"date-parts": [[2010]]}, "DOI": "10.1002/pros.21120", "type": "journal-article", "created": {"date-parts": [[2010, 2, 1]], "date-time": "2010-02-01T17:07:58Z", "timestamp": 1265044078000}, "page": "n/a-n/a", "source": "Crossref", "is-referenced-by-count": 1, "title": ["Regulation of androgen receptor transactivity and mTOR-S6 kinase pathway by Rheb in prostate cancer cell proliferation"], "prefix": "10.1002", "author": [{"given": "Takashi", "family": "Kobayashi", "sequence": "first", "affiliation": []}, {"given": "Yosuke", "family": "Shimizu", "sequence": "additional", "affiliation": []}, {"given": "Naoki", "family": "Terada", "sequence": "additional", "affiliation": []}, {"given": "Toshinari", "family": "Yamasaki", "sequence": "additional", "affiliation": []}, {"given": "Eijiro", "family": "Nakamura", "sequence": "additional", "affiliation": []}, {"given": "Yoshinobu", "family": "Toda", "sequence": "additional", "affiliation": []}, {"given": "Hiroyuki", "family": "Nishiyama", "sequence": "additional", "affiliation": []}, {"given": "Toshiyuki", "family": "Kamoto", "sequence": "additional", "affiliation": []}, {"given": "Osamu", "family": "Ogawa", "sequence": "additional", "affiliation": []}, {"given": "Takahiro", "family": "Inoue", "sequence": "additional", "affiliation": []}], "member": "311", "reference": [{"key": "10.1002/pros.21120-BIB1", "author": "Ferlay", "year": "2001", "volume-title": "Globocan 2000: Cancer incidence, mortality and prevalence worldwide, Version 1.0"}, {"issue": "4", "key": "10.1002/pros.21120-BIB2", "doi-asserted-by": "crossref", "first-page": "225", "DOI": "10.3322/caac.20006", "article-title": "Cancer statistics, 2009", "volume": "59", "author": "Jemal", "year": "2009", "journal-title": "CA Cancer J Clin"}, {"issue": "4", "key": "10.1002/pros.21120-BIB3", "doi-asserted-by": "crossref", "first-page": "366", "DOI": "10.1056/NEJMra021562", "article-title": "Prostate cancer", "volume": "349", "author": "Nelson", "year": "2003", "journal-title": "N Engl J Med"}, {"issue": "2", "key": "10.1002/pros.21120-BIB4", "doi-asserted-by": "crossref", "first-page": "222", "DOI": "10.1038/84879", "article-title": "Pten and p27KIP1 cooperate in prostate cancer tumor suppression in the mouse", "volume": "27", "author": "Di Cristofano", "year": "2001", "journal-title": "Nat Genet"}, {"issue": "13", "key": "10.1002/pros.21120-BIB5", "doi-asserted-by": "crossref", "first-page": "7841", "DOI": "10.1073/pnas.1232229100", "article-title": "Prostate intraepithelial neoplasia induced by prostate restricted Akt activation: The MPAKT model", "volume": "100", "author": "Majumder", "year": "2003", "journal-title": "Proc Natl Acad Sci USA"}, {"issue": "3", "key": "10.1002/pros.21120-BIB6", "doi-asserted-by": "crossref", "first-page": "E59", "DOI": "10.1371/journal.pbio.0000059", "article-title": "Pten dose dictates cancer progression in the prostate", "volume": "1", "author": "Trotman", "year": "2003", "journal-title": "PLoS Biol"}, {"issue": "10", "key": "10.1002/pros.21120-BIB7", "doi-asserted-by": "crossref", "first-page": "1105", "DOI": "10.1016/j.cellsig.2004.03.019", "article-title": "The Rheb family of GTP-binding proteins", "volume": "16", "author": "Aspuria", "year": "2004", "journal-title": "Cell Signal"}, {"issue": "11", "key": "10.1002/pros.21120-BIB8", "doi-asserted-by": "crossref", "first-page": "573", "DOI": "10.1016/j.tibs.2003.09.003", "article-title": "Rheb fills a GAP between TSC and TOR", "volume": "28", "author": "Manning", "year": "2003", "journal-title": "Trends Biochem Sci"}, {"issue": "16", "key": "10.1002/pros.21120-BIB9", "doi-asserted-by": "crossref", "first-page": "2172", "DOI": "10.1101/gad.1699608", "article-title": "Aberrant Rheb-mediated mTORC1 activation and Pten haploinsufficiency are cooperative oncogenic events", "volume": "22", "author": "Nardella", "year": "2008", "journal-title": "Genes Dev"}, {"issue": "12", "key": "10.1002/pros.21120-BIB10", "doi-asserted-by": "crossref", "first-page": "3053", "DOI": "10.1210/me.2006-0033", "article-title": "Requirement of androgen-dependent activation of protein kinase Czeta for androgen-dependent cell proliferation in LNCaP cells and its roles in transition to androgen-independent cells", "volume": "20", "author": "Inoue", "year": "2006", "journal-title": "Mol Endocrinol"}, {"issue": "3", "key": "10.1002/pros.21120-BIB11", "doi-asserted-by": "crossref", "first-page": "685", "DOI": "10.1111/j.1464-410X.2007.07014.x", "article-title": "Increased Akt and phosphorylated Akt expression are associated with malignant biological features of prostate cancer in Japanese men", "volume": "100", "author": "Shimizu", "year": "2007", "journal-title": "BJU Int"}, {"issue": "9", "key": "10.1002/pros.21120-BIB12", "first-page": "3051", "article-title": "Targeting AKT/mTOR and ERK MAPK signaling inhibits hormone-refractory prostate cancer in a preclinical mouse model", "volume": "118", "author": "Kinkade", "year": "2008", "journal-title": "J Clin Invest"}, {"issue": "6", "key": "10.1002/pros.21120-BIB13", "doi-asserted-by": "crossref", "first-page": "2134", "DOI": "10.1016/S0022-5347(05)65521-8", "article-title": "Real time reverse transcriptase polymerase chain reaction of urinary cytokeratin 20 detects transitional cell carcinoma cells", "volume": "166", "author": "Inoue", "year": "2001", "journal-title": "J Urol"}, {"issue": "2", "key": "10.1002/pros.21120-BIB14", "first-page": "334", "article-title": "Prostate-specific antigen promoter/enhancer driven gene therapy for prostate cancer: Construction and testing of a tissue-specific adenovirus vector", "volume": "60", "author": "Latham", "year": "2000", "journal-title": "Cancer Res"}, {"issue": "4", "key": "10.1002/pros.21120-BIB15", "doi-asserted-by": "crossref", "first-page": "226", "DOI": "10.1111/j.1440-1827.2008.02215.x", "article-title": "RHEB expression in fibroadenomas of the breast", "volume": "58", "author": "Eom", "year": "2008", "journal-title": "Pathol Int"}, {"issue": "2", "key": "10.1002/pros.21120-BIB16", "doi-asserted-by": "crossref", "first-page": "332", "DOI": "10.1016/j.urology.2005.02.028", "article-title": "Androgen receptor, Ki67, and p53 expression in radical prostatectomy specimens predict treatment failure in Japanese population", "volume": "66", "author": "Inoue", "year": "2005", "journal-title": "Urology"}, {"issue": "10", "key": "10.1002/pros.21120-BIB17", "doi-asserted-by": "crossref", "first-page": "5458", "DOI": "10.1073/pnas.96.10.5458", "article-title": "From HER2/Neu signal cascade to androgen receptor and its coactivators: A novel pathway by induction of androgen target genes through MAP kinase in prostate cancer cells", "volume": "96", "author": "Yeh", "year": "1999", "journal-title": "Proc Natl Acad Sci USA"}, {"issue": "24", "key": "10.1002/pros.21120-BIB18", "first-page": "6841", "article-title": "HER-2/neu promotes androgen- independent survival and growth of prostate cancer cells through the Akt pathway", "volume": "60", "author": "Wen", "year": "2000", "journal-title": "Cancer Res"}, {"issue": "4", "key": "10.1002/pros.21120-BIB19", "doi-asserted-by": "crossref", "first-page": "309", "DOI": "10.1016/j.ccr.2006.08.021", "article-title": "Regulation of androgen receptor activity by tyrosine phosphorylation", "volume": "10", "author": "Guo", "year": "2006", "journal-title": "Cancer Cell"}, {"issue": "2", "key": "10.1002/pros.21120-BIB20", "doi-asserted-by": "crossref", "first-page": "342", "DOI": "10.1097/01.ju.0000141580.30910.57", "article-title": "Cell lines used in prostate cancer research: A compendium of old and new lines-Part 1", "volume": "173", "author": "Sobel", "year": "2005", "journal-title": "J Urol"}, {"issue": "56", "key": "10.1002/pros.21120-BIB21", "doi-asserted-by": "crossref", "first-page": "7106", "DOI": "10.1038/onc.2008.318", "article-title": "Regulation of androgen receptor transcriptional activity by rapamycin in prostate cancer cell proliferation and survival", "volume": "27", "author": "Wang", "year": "2008", "journal-title": "Oncogene"}, {"issue": "7", "key": "10.1002/pros.21120-BIB22", "doi-asserted-by": "crossref", "first-page": "2547", "DOI": "10.1158/0008-5472.CAN-04-3411", "article-title": "Post-transcriptional regulation of the androgen receptor by mammalian target of rapamycin", "volume": "65", "author": "Cinar", "year": "2005", "journal-title": "Cancer Res"}, {"issue": "2", "key": "10.1002/pros.21120-BIB23", "doi-asserted-by": "crossref", "first-page": "159", "DOI": "10.1016/j.molcel.2006.03.029", "article-title": "Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB", "volume": "22", "author": "Sarbassov", "year": "2006", "journal-title": "Mol Cell"}, {"issue": "2", "key": "10.1002/pros.21120-BIB24", "doi-asserted-by": "crossref", "first-page": "89", "DOI": "10.1016/j.ccr.2006.07.013", "article-title": "Intracellular signaling in tumor and endothelial cells: The expected and, yet again, the unexpected", "volume": "10", "author": "Stoeltzing", "year": "2006", "journal-title": "Cancer Cell"}, {"issue": "2", "key": "10.1002/pros.21120-BIB25", "doi-asserted-by": "crossref", "first-page": "148", "DOI": "10.1016/j.ccr.2008.12.017", "article-title": "mTOR complex 2 is required for the development of prostate cancer induced by Pten loss in mice", "volume": "15", "author": "Guertin", "year": "2009", "journal-title": "Cancer Cell"}, {"issue": "5", "key": "10.1002/pros.21120-BIB26", "doi-asserted-by": "crossref", "first-page": "656", "DOI": "10.1016/j.cellsig.2009.01.004", "article-title": "Akt-dependent and -independent mechanisms of mTOR regulation in cancer", "volume": "21", "author": "Memmott", "year": "2009", "journal-title": "Cell Signal"}, {"issue": "9", "key": "10.1002/pros.21120-BIB27", "first-page": "3065", "article-title": "Inhibition of mTORC1 leads to MAPK pathway activation through a PI3K-dependent feedback loop in human cancer", "volume": "118", "author": "Carracedo", "year": "2008", "journal-title": "J Clin Invest"}, {"issue": "20 Pt 2", "key": "10.1002/pros.21120-BIB28", "doi-asserted-by": "crossref", "first-page": "6222s", "DOI": "10.1158/1078-0432.CCR-06-0843", "article-title": "Molecular mechanisms of action of bisphosphonates: Current status", "volume": "12", "author": "Roelofs", "year": "2006", "journal-title": "Clin Cancer Res"}, {"issue": "2", "key": "10.1002/pros.21120-BIB29", "doi-asserted-by": "crossref", "first-page": "183", "DOI": "10.1016/j.ctrv.2007.10.002", "article-title": "New research findings on zoledronic acid: Survival, pain, and anti-tumour effects", "volume": "34", "author": "Saad", "year": "2008", "journal-title": "Cancer Treat Rev"}, {"issue": "6", "key": "10.1002/pros.21120-BIB30", "doi-asserted-by": "crossref", "first-page": "644", "DOI": "10.1080/02841860510029617", "article-title": "Additive/synergistic antitumoral effects on prostate cancer cells in vitro following treatment with a combination of docetaxel and zoledronic acid", "volume": "44", "author": "Ullen", "year": "2005", "journal-title": "Acta Oncol"}, {"issue": "4", "key": "10.1002/pros.21120-BIB31", "doi-asserted-by": "crossref", "first-page": "521", "DOI": "10.1016/j.eururo.2003.12.012", "article-title": "Cytostatic and apoptotic effects of bisphosphonates on prostate cancer cells", "volume": "45", "author": "Dumon", "year": "2004", "journal-title": "Eur Urol"}], "container-title": ["The Prostate"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fpros.21120", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 2, 26]], "date-time": "2019-02-26T04:17:53Z", "timestamp": 1551154673000}, "score": 24.570835, "issued": {"date-parts": [[2010]]}, "references-count": 31, "URL": "http://dx.doi.org/10.1002/pros.21120", "relation": {"cites": []}, "ISSN": ["0270-4137", "1097-0045"], "issn-type": [{"value": "0270-4137", "type": "print"}, {"value": "1097-0045", "type": "electronic"}]}], "items-per-page": 20, "query": {"start-index": 0, "search-terms": null}}}